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IgA is the most abundant immunoglobulin produced in the body, most of which can be found 
at mucosal sites such as the intestine where it plays an important role at a critical intersection 
between the host immune system and the microbiota. In the work detailed here, I sought to 
investigate IgA delivery and stability using in vitro and in vivo methods. First, I developed a 
primary intestinal epithelial monolayer system, and utilized this system to evaluate factors that 
modulate IgA transcytosis. In vivo, I interrogated baseline levels of fecal IgA in WT mice and 
surprisingly observed a binary phenotype in fecal IgA levels between cages. I found that the 
dichotomous IgA levels were heritable, transmissible, and microbially driven. In addition, the 
IgA-Low phenotype was dominant and functionally resulted in increased intestinal injury by 
DSS. Utilizing the primary epithelial monolayer system and IgA transcytosis assay, I found that 
anaerobically cultured microbes from IgA-Low mice had proteolytic activity capable of 
degrading secretory component (SC) in vitro. These findings support the idea that degradation of 
SC in vivo would make IgA more susceptible to degradation itself. These studies highlight the 
ability of the microbiota to produce phenotypic effects through IgA modulation.  
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CHAPTER ONE 
 
Introduction: IgA in the Intestine 
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The intestine  
The intestinal mucosa is comprised of three main layers: the single cell epithelial layer 
that lines the inner surface of the intestine, the underlying lamina propria that is populated by 
many cell types from different lineages, and the muscularis mucosae that separates the mucosal 
layer from the underlying submucosa and muscularis layers. In the colon, the epithelial layer 
forms structures called crypts, whereas the small intestinal epithelium covers fingerlike 
projections called villi as well as the crypts. There are several different cell types found in the 
intestinal epithelium. Stem cells and progenitors found near the base of the crypts are important 
for the high turnover of epithelial cells. Absorptive enterocytes function in nutrient and water 
absorption. Secretory cell types include the hormone-secreting enteroendocrine cells, mucus 
secreting goblet cells, and small intestinal Paneth cells that secrete antimicrobial peptides in 
addition to mucus. 
The lamina propria contains many different cell types including immune cells such as 
dendritic cells, macrophages, and plasma cells. Mucosal sites are locations where the host is in 
direct contact with the environment, which includes  approximately 10
14 
commensal bacteria 
present in the intestinal lumen
1
. The immune system must be able to respond to any breaches in 
the epithelial barrier but at the same time control its responses to prevent chronic inflammation. 
It is thought that diseases such as inflammatory bowel disease (IBD) may arise from the 
dysregulation of the immune response to the commensal bacteria
2
.  
 
Plasma cells and IgA production 
Another highly secretory cell type found in the intestine is the immunoglobulin-secreting 
plasma cell. 75% of the total immunoglobulin produced in the body is made in the intestine, 
3 
 
where immunoglobulin A (IgA) is the predominant isotype produced
3
. Humans secrete ~3g of 
IgA in the intestine per day. While IgA can be found as a monomer in serum, the dimeric form 
(dIgA) covalently linked by the J chain (IgJ) is the predominant form at mucosal sites.  
Plasma cells develop from B cells after stimulation in either a T cell-dependent or T cell-
independent manner
4
. Ex vivo studies have found that transforming growth factor β (TGFβ) and 
interleukin (IL)-4 could promote naïve B cells to undergo IgA class switch when non-
specifically stimulated
5
. Furthermore, once IgA class switch has occurred, IL-2, IL-5, and IL-10 
had a synergistic effect in increasing IgA levels.  
In co-culture studies, dendritic cells were shown to be able to induce IgA class switch 
with or without the presence of T cells. Further studies using T cell receptor (TCR) β and δ chain 
deficient mice as well as CD40 deficient mice showed a substantial decrease but not absence of 
IgA. These studies suggested a T cell-independent pathway of IgA production. It is thought that 
in this pathway, intestinal epithelial cells and dendritic cells can produce cytokines such as 
APRIL and BAFF that can directly activate B cells to class switch to IgA without the need for 
antigen presentation on class II MHC, TCR engagement, or co-stimulation by CD40-CD40L. 
This is thought to mainly occur in isolated lymphoid follicles (ILFs), which require lymphoid 
tissue inducer (LTi) cells for their formation
6
.  
It has been hypothesized that the T-independent pathway may be important for protection 
against commensals, whereas the T-dependent pathway (which leads to affinity maturation by 
somatic hypermutation, and therefore more specific antibodies) might play a large role in defense 
against pathogens and toxins such as cholera toxin
7
. Using an activation-induced deaminase 
(AID) mutant mouse that can undergo class switch recombination but not somatic 
hypermutation, Wei et al observed that in the absence of affinity-maturation, a protective IgA 
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response to cholera toxin could not be generated
8
. More recent studies have shown however that 
the majority of IgA gene sequences in the gut are heavily mutated, arguing for the T-dependent 
IgA pathway as the major and dominant pathway for IgA production
9
.  
In the intestine, B cells can be found in the secondary lymphoid tissues such as Peyer’s 
Patches (T-dependent) and ILFs (T-independent). Upon stimulation, these cells develop into 
plasmablasts and eventually into mature plasma cells as they enter circulation through the 
lymphatics and home back to the lamina propria
5
, where a large number of mature IgA-secreting 
plasma cells can be normally found along the entire length of the gastrointestinal tract.  
 
IgA transcytosis and the polymeric immunoglobulin receptor 
While plasma cells produce and secrete dIgA locally in the lamina propria, most of its 
hypothesized roles are thought to occur in the lumen. To get from the lamina propria into the 
lumen, dIgA must bind to the polymeric immunoglobulin receptor (pIgR), which is expressed 
basolaterally on epithelial cells. The J chain, a 15 kDa polypeptide, is crucial for the ability of 
dIgA to bind to pIgR. In addition to dIgA, other multimeric immunoglobulins that possess the J 
chain (such as pentameric IgM) can also bind to pIgR as well
10,11
. The dIgA-pIgR complex is 
then endocytosed in clathrin-coated vesicles and transcytosed through the cell to the apical 
surface. At the cell surface, the receptor is cleaved
12
, releasing the dIgA still bound to the 
extracellular portion of pIgR (known as the secretory component; SC). This SC-bound dIgA 
(called secretory IgA; SIgA) is thought to be more resistant to cleavage by intestinal proteases 
due to the presence of the SC, J chain, and additional glycosylation residues
13,14
. 
The pIgR protein is a 120 kDa type I transmembrane protein expressed specifically in 
epithelial cells. Its expression can be found along the entire length of the gastrointestinal tract as 
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well as at other mucosal sites
15
. In rodents, there is also robust expression in the liver due to the 
hepatobilliary transport of IgA in these animals
16,17
. The extracellular portion of pIgR is 
composed of 5 immunoglobulin domains that are important for interacting with dIgA
11,18-20
. A 
small region, containing putative pIgR cleavage sites, separates these immunoglobulin domains 
from the transmembrane domain. The cytoplasmic C-terminal region contains a number of 
intracellular sorting signals. A great deal of work has been done in vitro using MDCK and 
human intestinal epithelial cell lines to dissect out the intracellular trafficking signals and 
pathways
21-25
. The binding of dIgA to pIgR has been shown to enhance pIgR transcytosis, 
however the unoccupied receptor can traffic to the surface to some extent as well
21,22,25
. 
Furthermore, this unoccupied pIgR can also be cleaved and released into the lumen, where it can 
play a role in host-defense independent of IgA. Free SC, which can be found in high 
concentrations in human colostrum and milk
19
, has been shown to bind to certain bacteria 
(enteropathogenic E.coli; EPEC) and antigens (C. difficile toxin A) to prevent their interaction 
with intestinal epithelial cells
26-28
.   
The enzyme that cleaves pIgR at the apical surface in vivo is still unknown
20
. The in vitro 
systems used to study pIgR have been comprised of many different cell types (intestine, liver, 
kidney; from multiple species). Yet in all of these systems, cleavage of pIgR has been observed, 
leading to the hypothesis that the enzyme of interest is either a widely expressed host protease, or 
there are multiple different proteases able to carry out this function. Further attempts to 
characterize the enzyme(s) involved have shown the protease involved to be sensitive to protease 
inhibitors leupeptin, antipain, E-64, and Aprotinin
12
. In addition, characterization of domain 6 of 
SC from human secretions did not find a consensus cleavage site
29,30
. These data suggest that 
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there are potentially multiple different enzymes that cleave pIgR in vivo, or that there is 
additional processing by host/bacterial peptidases after the initial cleavage event.  
 
Regulation of pIgR expression 
The expression of pIgR in the intestinal epithelium is regulated by bacterial stimuli
19,31-35
. 
In vitro studies have shown that stimulation of HT-29 cells with microbial factors such as heat 
killed bacteria, lipopolysaccharide (LPS), butyrate, and dsRNA can upregulate pIgR 
expression
32,33
. In addition, pro-inflammatory cytokines produced in response to microbial 
stimuli, such as interferon-γ (IFNγ), tumor necrosis factor-α (TNFα), IL-1β, IL-4 and IL-17 have 
also been shown to increase pIgR expression in vitro
19,36
. In vivo studies also support this idea, as 
germ-free mice monocolonized with Bacteroides thetaiotamicron have a 3-fold increase in pIgR 
expression in the ileum
31
. 
Promoter analysis of mouse and human pIgR has revealed binding sites for multiple 
transcription factors including IRF1, STAT6, and NFkB
37,38
. This is in agreement with the in 
vitro studies showing the ability of IFNγ (signaling through IRF1), IL-4 (signaling through 
STAT6), and TNFα (signaling though NFkB) to induce pIgR expression. Furthermore, bacterial 
ligands can signal through different toll like receptors (TLR) via Myd88 and NFkB to directly 
induce pIgR expression
38,39
. Epithelial-specific deletion of Myd88 showed a ~50% decrease in 
pIgR expression, suggesting a contribution of both Myd88-dependent and -independent 
pathways normally occurring in vivo. 
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Regulation of intestinal IgA induction 
Germ-free animals have markedly reduced intestinal plasma cell numbers and IgA, 
demonstrating the important role of microbes in the production of intestinal IgA
40
. To take a 
closer look at the timing and specificity of the IgA produced in the intestine, Hapfelmeier et al 
performed an elegant study using a novel reversible germ-free system
41
. In those experiments, an 
E. coli mutant requiring nutrients not produced by mammalian hosts was used. These mutants 
were able to survive in a nutrient-supplemented culture, but could not replicate and colonize the 
intestinal tract. Germ-free mice gavaged with this mutant strain became germ-free within 72 
hours. Despite the lack of colonization, a specific IgA response was observed, although a high 
dose of live bacteria was required to induce this response. This suggested an intrinsic threshold 
(between 10
8
-10
9
 bacteria) for the intestinal IgA response to occur. After exposure to this single 
bacterial strain, the plasma cells persisted for >16 weeks, despite the fact that germinal center B 
cells returned to baseline by 2-6 weeks in the absence of bacteria. In the presence of additional 
bacterial species however, the E.coli-specific IgA is rapidly lost due to ongoing induction of IgA 
by the colonized microbes. This result showed that the IgA response changed to the changing 
microbial population, allowing the mucosal immune system to adapt to the bacteria that are 
currently present.  
Older studies have shown that the average half-life of intestinal plasma cells was 5 days, 
with a maximum lifetime of 6-8 weeks in conventional mice
42
. These studies demonstrate the 
quicker turnover of plasma cells and most likely the changing IgA specificities in the presence of 
a diverse commensal microbiota. 
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What is the role of SIgA in the intestine? 
 Several knockout mice lacking luminal IgA have been created to look at the role of IgA 
in the intestine. Two different pIgR
-/-
 mice have been created by different groups, targeting 
different exons of the pIgR gene
43,44
. Both mice show essentially no IgA in the feces or luminal 
content, indicating the essential role of pIgR in the transport of IgA into the lumen. In addition, 
there is a significant increase in serum IgA levels (especially dIgA), as well as an increase in 
lamina propria IgA staining in the pIgR
-/- 
mice compared to heterozygous and wild type 
littermate controls. Further studies showed that there is an increase in IgA
+
 plasma cell numbers 
in the lamina propria of the pIgR
-/- 
mice
45
. The IgJ
-/-
 mouse also shows a similar phenotype as the 
pIgR
-/-
, with decreased luminal IgA and increased serum IgA
46,47
. Additional mice lacking 
luminal IgA (among other things) include the immunodeficient SCID and RAG
-/-
 mice, class-
switch deficient AID
-/-
 mouse as well as the IgA
-/-
 mouse
48
. The IgA
-/-
 mice show an increase in 
other immunoglobulin isotypes, and there is concern in the field of disregulated class switching 
due to the fact that the IgA switch region was targeted in addition to several of the Cα exons.  
The functional significance of this lack in luminal IgA has been tested using several 
models, and there are several hypotheses in the field. Infection studies looking at intestinal and 
lung pathogens in pIgR
-/-
 and IgJ
-/-
 mice show that SIgA is important in protecting against 
secreted toxins at the mucosal sites
47,49
 and preventing colonization of bacterial pathogens
49,50
. 
However, systemic immune responses seem to be intact, as pIgR
-/-
 mice are able to survive and 
clear systemic infection with Salmonella typhimurium and Streptococcus pneumoniae after 
mucosal immunization just as well as wild type mice. In addition, uninfected pIgR
-/-
 mice show 
increased translocation of gut commensal bacteria to the MLNs compared to wild type mice 
along with an increase in serum IgA and IgG reactivity to the commensal bacteria
51
.  This 
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supports the idea that luminal IgA is important in limiting bacterial translocation across the 
epithelium. Furthermore, IgA may play a role in regulating the composition of the normal 
commensal bacterial population, as AID
-/-
, RAG
-/-
, and SCID mice all show alterations in their 
intestinal microbiota compared to wildtype or littermate controls
4,52
. Finally, using OVA-specific 
TCR transgenic mice, it has been shown that epithelial cells can transport antigen-bound dIgA 
from the lamina propria into the lumen via pIgR, thereby eliminating antigens that have crossed 
the intestinal epithelial barrier
53
.  
Despite these many hypothesized roles and experimental systems utilized to address these 
hypotheses, direct and definitive evidence for the exact function of IgA in vivo is still lacking 
and there is still debate in the field as to its functional significance
7
.  
 
Selective IgA deficiency in humans 
 In humans, IgA deficiency (IGAD) is the most common primary immunodeficiency, with 
frequencies ranging between 1:223 and 1:1000 in different US populations
54
. It is defined as 
decreased or absent serum IgA in the presence of normal IgM and IgG. Most people with IGAD 
are asymptomatic and many more are thought to go undiagnosed due to the general nature of the 
symptoms. Patients with this disorder develop allergies, autoimmune manifestations, and 
recurrent infections at mucosal sites. Additionally, selective IgA deficiency has been associated 
with several gastrointestinal disorders including celiac disease, colon cancer, and IBD. These 
manifestations suggest an important role for IgA at mucosal sites, however, IgA levels at 
mucosal sites have not been thoroughly investigated in humans, as diagnosis is usually limited to 
serum-based methods. As the mucosal immune compartment is thought to be distinct and 
separate from the systemic immune compartment, there could be IgA deficiencies specifically at 
10 
 
mucosal sites through several different mechanisms that have not been observed or investigated 
in the context of mucosal diseases such as IBD.  
  In 1976, a case study was published on a 15 year old patient with normal serum 
immunoglobulins, but specifically lacking mucosal IgA
55
. This patient was breast fed until 3.5 
months of age, after which he developed persistent intermittent diarrhea. Antibiotic treatment 
and dietary changes did not resolve the symptoms, and multiple stool samples were negative for 
parasites. Small intestinal biopsy samples revealed increased lamina propria lymphoid cells, and 
in vitro stimulation of peripheral blood lymphocytes showed normal proliferation and 
immunoglobulin secretion. Unlike IGAD patients, free secretory component was not found in 
saliva or jejunal fluid. At this time the role of SC and the identity of pIgR were unknown, 
however the evidence presented here suggests that the patient may have a defect in IgA 
transcytosis by pIgR. This case study shows the significance of maternally transferred IgA, as 
well as the role of IgA in maintaining intestinal homeostasis.  
 A recent study looking at Crohn’s Disease (CD) patients identified a subset of patients 
with reduced pIgR expression in the colon along with elevated serum IgA levels and increased 
IgA staining in the lamina propria
56
. This mirrors what is observed in the pIgR
-/-
 mice. These two 
examples demonstrate potential consequences of the lack of luminal SIgA in the presence of 
normal or even elevated systemic IgA, and further supports the idea that serum IgA cannot 
necessarily be used as a read-out for mucosal IgA.  
 
Commensal bacteria in the intestine 
There is an estimated 10
14
 microbes present in the intestinal lumen representing at least 
500-1000 individual species
1
. These commensal bacteria are acquired shortly after birth, and 
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many of these microbes are thought to be maternally transmitted
57-59
. Sequencing of the gut 
microbiome has revealed Bacteroidetes and Firmicutes as the two major phyla found in the 
intestine
60,61
. Despite the fact that these commensal bacteria greatly outnumber host cells, the 
idea that microbes can modulate host phenotypes is sometimes overlooked in studies using 
genetically modified mice. While there are many phenotypes that are a clear and direct 
consequence of host genetics, there have been many cases where the assumed genetically-
induced phenotype may in fact be driven solely by differences in the commensal microbiota
62-67
. 
In some cases, opposing results using the same genetic knockout mouse in different facilities has 
led to controversy and argument in the field
62,68,69
. It has therefore become crucial to take into 
account both host genetic and microbial factors in studies, especially those involving mucosal 
sites.  
 
Degradation of SIgA by pathogenic bacteria 
 Although there is still debate over the role and even significance of IgA, the fact that 
there are pathogenic bacteria that can degrade IgA strongly supports the idea that IgA plays an 
important role in host-microbial interactions and intestinal homeostasis. Beginning in the 1970s, 
several groups have identified pathogenic bacteria producing related proteases that specifically 
cleave human IgA1 at Pro-Ser and Pro-Thr residues in the IgA hinge region
70-72
. The bacterial 
strains, isolated from human patients, include Neisseria gonorrheae, Neisseria meningitides, 
Haemophilus influenza, and Streptococcus pneumonia. Importantly, the related non-pathogenic 
members/commensal species of these bacteria did not even possess the IgA1 protease genes, 
suggesting that these genes could be virulence factors
73,74
.   
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 A recent study showed one mechanism of how this ability to degrade IgA can benefit the 
bacterial pathogen
75
. Janoff et al showed in vitro that exogenously and endogenously produced 
IgA1 protease cleaved capsule-specific monoclonal human IgA1 antibodies that recognized the 
bacterial surface of S. pneumonia. This in turn inhibited the Fc-mediated phagocytic killing of 
the microbe, and furthermore left the Fab fragments still bound to the antigenic residues on the 
bacterial surface, making these bacteria in effect immunologically hidden.  
While human IgA1 is more abundant at non-mucosal sites, the identification of bacterial 
IgA1 proteases led to the idea that there could be pathogens that cleave the mucosally-dominant 
human IgA2. In fact, several examples of bacteria able to cleave human IgA2 have been 
identified
73,76,77
. Like the classical IgA1 proteases, these proteases have been isolated from 
bacterial pathogens (Clostridial species from IBD and Proteus species from urinary tract 
infections). While the some of the identified proteases may be more specific for IgA, Proteus 
mirabilis has been shown to produce a metalloprotease called ZapA that is able to cleave a wide 
variety of proteins, including immunoglobulins (IgA1, IgA2, IgG), SC, complement (C1q, C3), 
antimicrobial peptides (hBD1, LL-37), and structural proteins (collagen, fibronectin, laminin, 
actin, tubulin)
78,79
.  
The bacterial IgA proteases identified to date have great specificity for their host species. 
For example, the bacterial IgA1 proteases from human isolates have limited reactivity and are 
only specific for human IgA1, and in some cases chimpanzee and gorilla IgA1
80,81
. Furthermore, 
multiple strains of canine Ureaplasma isolates were shown to cleave canine IgA, but did not 
have proteolytic activity against human  or murine IgA
81
. The identification of these broad and 
specific IgA proteases produced by pathogenic bacteria with host specificity highlights the 
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significant impact that IgA has played in the evolutionary conversation between the host and 
microbes.  
 
Modeling the intestine in vitro  
Many advances in the last few decades have made the study of gastrointestinal tract 
possible, including the development of genetically and microbially defined animal models, 
animal models of injury and repair, and immortalized cell lines. Most recently, the ability to 
grow and propagate primary intestinal epithelial cells in vitro has greatly advanced the field.  
Sato et al developed an intestinal crypt culture system from single Lgr5
+
 cells isolated 
from the mouse intestine that required exogenous growth factors in the media (EGF, R-spondin1, 
and Noggin)
82
. The single Lgr5
+
 cells, suspended in Matrigel, were shown to form crypt-villus 
structures termed organoids, and contained multiple cell types including enterocytes, Paneth 
cells, goblet cells, and enteroendocrine cells. These organoids could be dissociated and re-plated 
to form new organoids every 14 days. While this was a major breakthrough in the field, the 
exogenous factors required to maintain these cells are expensive and can be cost-prohibitive to 
maintain for the large-scale cultures that are required for standard in vitro assays.  
Miyoshi et al developed a system to culture enriched gastrointestinal stem cells using 
conditioned medium from a supportive cell line (L-WRN) containing Wnt3a, R-spondin3, and 
noggin
83,84
. This system not only provided a cost-effective method to grow primary intestinal 
stem cells, it also allowed for the use of whole tissue as starting material, eliminating the need to 
sort and purify stem cells prior to the start of culture. Despite the heterogeneous cell population 
in the starting material, the culture conditions here specifically allowed for the growth and 
propagation of the stem cell population. Unlike the organoid system, these enriched stem cells 
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did not form budding structures and instead formed spheroids. However, these cells were able to 
differentiate into multiple cell types by decreasing the amount of conditioned media and adding 
the γ secretase inhibitor DAPT. Furthermore, these cells could be passaged every 3 days, as 
opposed to the 14 days required by the organoid system. In addition, the L-WRN conditioned 
media has allowed for establishment of epithelial spheroid cultures from human gastrointestinal 
tissue and biopsy samples (VanDussen et al in press).  
Prior to the ability to grow primary intestinal epithelial cells, colon cancer cell lines have 
been widely used to model physiologic and cell biologic intestinal processes in vitro, and these 
studies have provided great insight into epithelial cell biology. However, there are many well-
recognized limitations to these lines including prolonged time to attain mature and differentiated 
monolayers (~20 days in culture for some lines), aneuploidy, and the presence of numerous 
undefined DNA mutations. Additional alternatives to human cancer cell lines have been 
developed and include the use of virally-transformed intestinal epithelial cells such as rat IEC-18 
cells, or non-intestinal epithelial cells such as MDCK cells, but these systems have their own 
limitations
85,86
. One major advantage these various cell lines have over the current primary 
intestinal epithelial culture method is their ability to form polarized monolayers in Transwells. 
This has provided the means to study many epithelial cell processes including interactions with 
other host cell types, interactions with microbes, drug absorption, and intracellular 
trafficking
85,87,88
. The development of a primary intestinal epithelial monolayer system would 
allow for a more physiologic model to investigate these different intestinal epithelial processes in 
vitro. 
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ABSTRACT 
There is significant interest in the use of primary intestinal epithelial cells in monolayer 
culture to model intestinal biology. However, it has proven to be challenging to create functional, 
differentiated monolayers using current culture methods, likely due to the difficulty in expanding 
these cells. Here, we adapted our recently developed method for the culture of intestinal 
epithelial spheroids to establish primary epithelial cell monolayers from the colon of multiple 
genetic mouse strains. These monolayers contained differentiated epithelial cells that displayed 
robust transepithelial electrical resistance. We then functionally tested them by examining IgA 
transcytosis across Transwells. IgA transcytosis required induction of pIgR expression, which 
could be stimulated by a combination of lipopolysaccharide and inhibition of -secretase. In 
agreement with previous studies using immortalized cell lines, we found that TNFα, IL-1β, IL-
17, and heat-killed microbes also stimulated pIgR expression and IgA transcytosis. We used 
wild-type and knockout cells to establish that among these cytokines, IL-17 was the most potent 
inducer of pIgR expression/IgA transcytosis. IFN, however, did not induce pIgR expression, 
and instead led to cell death. This new method will allow the use of primary cells for studies of 
intestinal physiology. 
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INTRODUCTION 
The study of intestinal epithelial biology has been made feasible through advances in the 
field of gastroenterology during the last few decades. Some of these technical advances have 
included the development of genetically and microbiologically defined animal models, animal 
models of injury and repair, and immortalized epithelial cell lines for in vitro studies. Most 
recently, the ability to propagate primary intestinal epithelial cells in vitro has greatly advanced 
the field
82-84
.   
Prior to the ability to grow primary intestinal epithelial cells, colon cancer cell lines have 
been widely used to model physiologic and cell biologic intestinal processes in vitro. Studies 
using these lines have provided initial insights into epithelial biology in many areas.  For 
example, Caco-2, HT-29, and T84 cells can form monolayers of differentiated cells
89-91
. 
However, colon cancer cell lines have many well-recognized limitations including prolonged 
time to attain mature monolayers (~20 days in culture for some lines), aneuploidy, and the 
presence of numerous undefined DNA mutations. Additional alternatives to human cancer cell 
lines have been developed and include the use of virally-transformed intestinal epithelial cells 
such as rat IEC-18 cells, or non-intestinal epithelial cells such as MDCK cells, but these systems 
also have limitations
85,86
. 
 One advantage these various cell lines have over the current primary intestinal epithelial 
cell culture method is their ability to form polarized monolayers in Transwells. This has provided 
the means to study many epithelial cell processes including interactions with other cell types, 
interactions with microbes, drug absorption, and intracellular trafficking
85,87,88
. One such 
intestinal epithelial cell process that has been well-dissected and characterized using these cell 
lines is IgA transcytosis via pIgR
11,19,38
. 
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 The majority (75%) of the total immunoglobulin produced in the body is made in the 
intestine, where IgA is the predominant isotype produced
3
. Humans secrete ~3 g of IgA in the 
intestine per day. While IgA can be found as a monomer in serum, the dimeric form (dIgA) 
connected by the J chain (IgJ) is the predominant form at mucosal sites
20
.  
 Plasma cells produce and secrete dIgA locally in the lamina propria. For the IgA to enter 
the intestinal lumen, dIgA must bind to its receptor pIgR
92,93
, which is expressed basolaterally on 
epithelial cells. The dIgA-bound pIgR is then endocytosed in clathrin-coated vesicles and 
transcytosed across the cell through several distinct compartments to the apical surface
11,19,94
. At 
the cell surface, as of yet unidentified enzymes cleave the receptor, releasing the dIgA still bound 
to the extracellular portion of pIgR (known as the secretory component, or SC). This secretory 
IgA (SIgA), protected by the J chain as well as the SC, is more resistant to cleavage by intestinal 
proteases
13,14
.  
 Several studies have shown that the expression of pIgR in the intestinal epithelium is 
regulated by bacterial stimuli. Germ free mice have a 3-fold increase in pIgR expression in the 
ileum upon monocolonization with Bacteroides thetaiotamicron
31
. In vitro studies have shown 
that stimulation of HT-29 cells with microbial factors (such as LPS, butyrate, and dsRNA) or 
heat-killed bacteria can upregulate pIgR expression
32,33
. Pro-inflammatory cytokines produced in 
response to microbial stimuli, such as IFNγ, TNFα, IL-1, and most recently IL-17 have also been 
shown to increase pIgR expression in vitro
19,36,38,95-98
.  
 Here for the first time, we establish a system to grow primary intestinal epithelial cell 
monolayers. This will assist in the study of intestinal epithelial cell processes in vitro using 
primary cells. We chose to focus on the process of IgA transcytosis using this system. We were 
able to adapt the previously established three dimensional (3D) primary intestinal epithelial stem 
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cell culture system into a 2D monolayer in a Transwell. These cells are able to express pIgR after 
stimulation with LPS, and transcytose IgA across the monolayer. TNFα, IL-1β, and IL-17 were 
able to induce pIgR expression and IgA transcytosis in a dose-dependent manner. Importantly, 
perhaps demonstrating a distinction with previous methodologies using immortalized cell lines, 
IFN did not enhance pIgR expression. Heat-killed bacteria were also able to stimulate these 
processes to differing extents. Finally, this system will be readily adaptable for the use with 
available genetically modified mice to study different genes of interest: primary intestinal 
epithelial cells from pIgR
-/-
 mice do not show IgA transcytosis into the supernatants, while cells 
from Tlr4
-/-
 mice have reduced pIgR expression and IgA transcytosis after LPS stimulation 
compared to wild-type cells. 
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MATERIAL AND METHODS                 
Mice. Animal protocols were approved by the Washington University Animal Studies 
Committee. All mice were maintained in a specific pathogen-free barrier facility. pIgR
-/-
 mice 
(B6.129P2-Pigr
tm1Fejo
/Mmmh
43
) were initially obtained from Mutant Mouse Regional Resource 
Center (Columbia, MO). Tlr4
-/-
 mice were provided by the laboratory of Dr. William F. Stenson 
(B6.B10ScN-TLR4
lps-del
/JthJ from Jackson Laboratory
99
). All mice used were 8-10 weeks of age.  
 
3D spheroid cell culture. Primary colonic epithelial stem cells were isolated, grown, and 
maintained as 3D spheroid cultures in Matrigel (BD Biosciences; San Jose, CA) as described in 
Miyoshi et al
83,84
. Cells were kept in 50% L-WRN conditioned media (CM). Media was changed 
every two days, and cells were passaged every three days (1:3 split).  
 
Formation of Transwell monolayers. To form monolayers of intestinal epithelial cells, 
spheroids were taken from three-day-old 3D cultures for plating in Transwells (Corning Costar 
3413; Tewksbury, MA). The Transwells were coated in 0.1% gelatin for >1 hour at 37°C. 
Spheroids were recovered from Matrigel by first washing in a solution of 0.5 mM 
ethylenediaminetetraacetic acid (EDTA), and then dissociated for 4 minutes at 37°C using a 
solution of 0.05% Trypsin/0.5 mM EDTA. The trypsin was then inactivated using 
DMEM/F12media containing 10% FBS. The spheroids were then dissociated by vigorous 
pipetting (using a 1000 μl pipet). The cells were then passed through a 40 μm cell strainer (BD 
Biosciences) and re-suspended in 50% L-WRN CM containing 10 μM Y-27632 (ROCK 
inhibitor; Tocris Bioscience and R&D Systems; Minneapolis, MN). On average, spheroids from 
three wells of a 24-well plate were plated into the upper compartment of a single Transwell in 
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100μl of media. An additional 600 μl of media was added to the lower compartment of the 
Transwells.  
 
Cell treatments. On day one (24 hours after seeding the Transwells) the 50% L-WRN CM 
supplemented with Y-27632 was removed and replaced with 0% CM (Advanced DMEM/F12 
containing 20% FBS, 100 units of Penicillin, 0.1 mg/ml Streptomycin and 2mM L-glutamine). 
At this time, any additional treatments were also administered to the cells: LPS (Sigma L4391; 
Saint Louis, MO), DAPT -secretase inhibitor (Millipore 565784; Billerica, MA), recombinant 
mouse IL-1β (R&D Systems 401-ML), recombinant mouse IFN (R&D Systems 485-ML), 
recombinant mouse TNFα (R&D Systems 410-MT), recombinant mouse IL-17 (R&D Systems 
421-ML), and heat-killed E. coli (lab stocks, mouse adapted strain)
100
. Cells were given fresh 
media with the respective treatments on day two, and were treated for a total of 48 hours before 
being used for IgA transcytosis, histology, or RNA extraction on day three.  
 
Transepithelial electrical resistance (TER) measurements. TER was measured for cells in 
Transwells using an epithelial volt-ohm meter (World Precision Instruments, Inc.; Sarasota, FL). 
Resistance of the intestinal epithelial cell monolayer was calculated by subtracting the resistance 
of the (membrane + media) from the resistance of the (membrane + media + cells). Each 
Transwell was measured in triplicate and the average value was taken. This value was then 
multiplied by the area of the Transwell membrane (0.33 cm
2
) to obtain a final value in Ωcm2. 
 
IgA transcytosis assay. On day three, the Transwells were removed from the various treatment 
conditions and washed with 0% CM. 600 μl of 0% CM containing mouse IgA (for early studies: 
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Santa Cruz Biotechnology sc-3900; Dallas, TX; later studies: BD Pharmingen 553476) was 
added to the lower compartment. Both sources of IgA contained a mixture of monomeric and 
polymeric IgA, according to each company. For the lot of BD Pharmingen IgA used in these 
studies, the amount of dimeric IgA was ~85% according to the manufacturer. 100 μl of 0% CM 
alone was added to the upper compartment and collected at different time points to evaluate the 
amount of IgA transcytosed by ELISA (Immunology Consultants Labs E-90A; Portland, OR).   
 
Immunostaining and histologic analysis. Cells in the Transwells were washed with PBS and 
fixed in either 10% formalin or Bouins fixative for 10 minutes. The cells were then washed three 
times in 70% ethanol and the Transwell membranes were cut out from the Transwell inserts 
using a surgical blade. The membranes were processed for paraffin embedding. 5 μm thick 
transverse sections were cut for hematoxylin and eosin staining and immunostaining. For this 
procedure, the sections were de-paraffinized, hydrated, boiled in Trilogy solution (Cell Marque; 
Rocklin, CA) for 20 minutes, rinsed in PBS, blocked with 1% bovine serum albumin/0.1% 
Tritin-X100 for 30 minutes, and incubated with primary antibody at 4°C overnight. Primary 
antibodies include: rabbit anti-ZO-1 (1:100, Invitrogen/Life Technologies; Grand Island, NY), 
mouse anti-chicken Villin1 (1:100, AbDSerotec; Raleigh, NC), and goat anti-pIgR (1:500, R&D 
Systems). The slides were rinsed three times in PBS and then incubated with AlexaFluor594- or 
AlexaFluor488-conjugaed species-specific secondary antibodies for one hour at room 
temperature (1:500, Invitrogen/Life Technologies). Slides were washed three times in PBS and 
stained with bis-benzimide (Hoescht 33258, Invitrogen/Life Technologies) to visualize nuclei 
and mounted with a 1:1 PBS:glycerol solution. Staining was visualized with a Zeiss 
(Oberkochen, Germany) Axiovert 200 microscope with an Axiocam MRM digital camera. 
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 For whole mount immunostaining, cells were fixed and washed in the Transwells as 
described above, then washed three times with PBS before they were cut out from the Transwell 
inserts and placed in the wells of a 24-well plate. The membranes were then blocked and stained 
as described above. Nuclei counts were made using ImageJ
101
. For whole tissue immunostaining, 
mouse colons were harvested and prepared as previously described
102
. 
 
Gene expression analysis. RNA was isolated from cells in the Transwells on day three after 
seeding using the NucleoSpin RNA II isolation kit (Macherey-Nagel; Bethlehem, PA). 
Complementary DNA (cDNA) synthesis was performed using 0.2 μg of RNA and the 
SuperScript III reverse transcriptase (Life Technologies). Quantitative PCR reactions (qPCR) 
were performed with SYBR Advantage qPCR Premix (Clontech; Mountain View, CA). 
Expression levels were determined in triplicate per sample and normalized to the expression of 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh). Primers used include: Gapdh for 5’-AGG 
TCG GTG TGA ACG GAT TTG-3’, Gapdh rev 5’- TGT AGA CCA TGT AGT TGA GGT CA-
3’, pIgR for 5’-ATG AGG CTC TAC TTG TTC ACG C-3’, pIgR rev 5’-CGC CTT CTA TAC 
TAC TCA CCT CC-3’, Villin1 for 5’-ATG ACT CCA GCT GCC TTC TCT-3’, Villin1 rev 5’-
GCT CTG GGT TAG AGC TGT AAG-3’, Reg3g for 5’-CATCAACTGGGAGACGAATCC-3’, 
Reg3g rev 5’-CAGAAATCCTGAGGCTCTTGACA-3’, Muc2 for 5’-ATG CCC ACC TCC 
TCA AAG AC-3’, Muc2 rev 5’-GTA GTT TCC GTT GGA ACA GTG AA-3’, Atoh1 for 5’-
GAG TGG GCT GAG GTA AAA GAG T-3’, and Atoh1 rev 5’-GGT CGG TGC TAT CCA 
GGA G-3’.  
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RESULTS                 
Developing a Transwell system for mouse primary intestinal epithelial cells 
A critical roadblock to understanding intestinal physiology has been the lack of an 
experimental system to model primary intestinal epithelial cells as a polarized, confluent 
monolayer. The use of primary cells is of interest due to the differentiation potential of these 
cells in vitro
82
 as well as the need to evaluate cells from genetically modified mice. It has been 
challenging to adapt primary intestinal epithelial cells to Transwell culture as monolayers 
because this technique requires substantial numbers of viable cells.  
 We have solved this problem using an in vitro experimental system that allowed for 
significant expansion of intestinal epithelial stem/progenitor cells
83,84
. To obtain cells for a single 
Transwell, we harvested colonic spheroids from three wells (400-500 spheroids/well) of a 24-
well plate that were cultured as spheroids for three days in Matrigel using 50% L-WRN (L-cells 
expressing Wnt3a, R-spondin3, and Noggin) conditioned media (CM). This produced ~5x10
5
 
cells that were seeded onto a single 0.33 cm
2
 Transwell insert of a 24-well plate. Typically this 
cell input created a monolayer of ~2.5x10
5
 cells. At the time of seeding cells in Transwells, we 
used 50% L-WRN CM that also contained 10 μM of the ROCK inhibitor Y-27632 (Figure 2.1). 
The media was maintained for one day post-seeding.  
 On day one after seeding, the 50% CM was replaced with 0% CM supplemented with or 
without specific treatments that were designed to facilitate the study of IgA transcytosis. The 
treatment included a combination of the -secretase inhibitor DAPT to differentiate the 
cells
103,104
, and LPS to induce the expression of pIgR (which is known to be regulated by 
microbial and/or cytokine signaling)
31
. The cells were treated for two days in this media prior to 
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evaluation for differentiation by histology and gene expression analysis, as well as functional 
assays such as IgA transcytosis.  
 We next evaluated the effects of DAPT+LPS on differentiation and lineage allocation of 
primary epithelial monolayers. Cells were fixed on the Transwell membrane, which was then cut 
out of the insert and processed for paraffin embedding. Histologic sections were cut and stained 
with hematoxylin and eosin. We observed that both untreated and DAPT+LPS-treated cells 
showed a single layer of cells overlying the Transwell membrane (Figure 2.2a). To confirm that 
differentiation of enterocytes occurred both with and without DAPT+LPS treatments, we 
performed immunostaining using antisera against ZO-1 and Villin (Figure 2.2b,c). ZO-1 is a 
tight junction marker
105
 and Villin1 marks microvilli
106
. In addition, both of these proteins 
showed appropriate apical localization throughout the monolayer and this pattern was present 
regardless of treatment. We also found that a basolateral marker, CD138, showed appropriate 
localization in Transwell cultures (Figure 2.2d). Taken together, the localization of these 
markers is consistent with polarized epithelial cells. We stained for markers of additional colonic 
epithelial lineages including enteroendocrine cells (chromogranin A
107
) and goblet cells (lectin 
UEA-1
108
). Whole mount images of immunostained Transwells showed that both of these cell 
types were present in DAPT+LPS-treated monolayers with lower fractional representation than 
absorptive enterocytes (Figure 2.3). This lineage allocation is similar to what is observed in vivo 
for the surface epithelium of the mouse colon (Figure 2.4).  
 To adapt this experimental system for the study of IgA transcytosis, we evaluated the 
expression of pIgR both in vivo and in vitro. The colonic epithelium, including surface epithelial 
cells, expressed pIgR in vivo (Figure 2.5). In vitro, pIgR could be induced in epithelial 
monolayers that were treated with DAPT+LPS, as shown by immunostaining (Figure 2.2e). To 
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quantify the relative effects of DAPT and LPS on pIgR expression, we performed qRT-PCR of 
mRNAs isolated from epithelial cells grown on Transwells for three days. The addition of 
DAPT+LPS stimulated a robust increase in pIgR mRNA expression compared to untreated cells 
(~100-fold increase) (Figure 2.6). This finding corroborated the effects of DAPT+LPS on 
protein expression as determined by immunostaining (Figure 2.2e). Single treatment with either 
LPS or DAPT did not stimulate pIgR mRNA expression to the extent that was achieved by the 
combination of these factors. As a positive control for LPS treatment, expression of RegIII109 
was increased after DAPT+LPS treatment (Figure 2.7a). As a negative control, Villin1 
expression (which is not microbially regulated in vivo
110
) was similar in all groups of treated and 
untreated cells (Figure 2.7b). Thus, we were able to show that wild-type primary colonic 
epithelial cells on Transwells were responsive to DAPT+LPS.  
 To perform IgA transcytosis experiments, a complete monolayer of cells is required. To 
demonstrate that the seeded cells formed a functional monolayer, we measured transepithelial 
electrical resistance (TER) in the Transwells on day three (Figure 2.8).  For this experiment, we 
used cells at a density of ~2.5x10
5 
cells/0.33 cm
2
. The average TER of untreated cells was    
3333 Ωcm2. The TER of DAPT+LPS-treated cells was similar to the TER of untreated cells 
(2877 Ωcm2). 
 
Developing an IgA transcytosis assay using primary mouse Transwell cultures 
One of the critical functions of the intestinal epithelium is the transcytosis of IgA from 
the lamina propria to the lumen of the intestine. This process involves pIgR trafficking across the 
intestinal epithelium which can occur at a slower rate in the absence of IgA
25
. To determine if the 
primary intestinal epithelial monolayers were capable of IgA transcytosis, we developed an assay 
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utilizing these cells. At day three post-plating on Transwell inserts, the cells were washed and 
placed in wells containing normal mouse IgA in the lower compartment (Figure 2.9a). This 
media is in contact with the basolateral surface of the epithelial monolayer. Media alone was 
added to the upper compartment (apical surface). The cells were incubated at 37°C for different 
periods of time to allow for receptor binding and transcytosis to occur before the media in the 
upper compartment was sampled for analysis by enzyme-linked immunosorbent assay (ELISA) 
(Figure 2.9b). Colonic cells isolated from pIgR
-/-
 mice were used as a negative control for all 
transcytosis experiments.  
 Consistent with the pIgR mRNA expression data, cells treated with DAPT+LPS showed 
measurable IgA in the apical media whereas the other three groups (untreated, DAPT alone, and 
LPS alone) had levels at or below the limit of detection (Figure 2.10). Apical media from pIgR
-/-
 
cells did not contain IgA regardless of treatment. This genetic control indicated that IgA is 
actively transported through epithelial cells and does not use paracellular transport.   
 To determine the optimal conditions for transcytosis experiments, we performed IgA 
dose curve and time course experiments using DAPT+LPS-treated cells. One hour after the 
addition of IgA to the basal compartment, no IgA was detected in the apical media (Figure 
2.11). Therefore, one hour was not sufficient for IgA in the basal compartment to bind pIgR and 
transcytose across cells to the apical compartment. This result also showed that the monolayer 
was intact and thus did not allow the IgA to freely diffuse into the apical media. Because of this 
result, we utilized the one hour time point as an additional internal control in all subsequent 
experiments. Additional time points were taken three hours (four hours after the addition of IgA) 
and six hours later (ten hours after the addition of IgA). Both of these time points showed 
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progressively higher levels of IgA in the apical media (Figure 2.11). In subsequent experiments, 
all three of these time points were evaluated.  
 In choosing the optimal dose of IgA, the amount of IgA in the apical compartment at 
three and six hour time points needed to be in linear range of the ELISA. We initially used 
normal mouse IgA from Santa Cruz Biotechnology at a dose of 40 µl/well (Figure 2.12a). In 
later experiments, we used normal mouse IgA from BD Pharmingen at a comparable dose, which 
allowed for a more precise measurement of IgA concentration and decreased variability between 
experiments (Figure 2.12b). For this source of IgA, we were able to calculate the IgA 
concentration used to 5 µg/ml, or a total of 3 µg/well. 
 As it was unclear how sensitive primary wild-type colonic epithelial cells were to LPS, 
we performed a dose-response curve for LPS using both IgA transcytosis and pIgR expression as 
readouts (Figure 2.13). Both transcytosis and pIgR mRNA expression responded in a dose-
dependent manner. In all subsequent experiments, we used 1 μg/ml LPS as this was in linear 
range of the response of wild-type cells. 
 Although LPS has been used as a standard in the field to efficiently induce pIgR 
expression in different cell types, there is growing interest in the study of the effects of specific 
microbes in the intestine and how they stimulate IgA
32-34,39,111
. To model an example of such 
host-microbial interactions in vitro, cells were treated with heat-killed E. coli to analyze its 
ability to induce IgA transcytosis and pIgR expression (Figure 2.14). A dose equivalent to 10
7
 
CFU/ml E. coli was found to induce similar levels of IgA transcytosis and pIgR expression as 
that demonstrated for to 1 µg/ml LPS.  
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Cell density affects IgA transcytosis and pIgR expression in Transwell cultures 
We noticed that there was occasional experiment-to-experiment variability of the amount 
of IgA transcytosed. Further scrutiny of the Transwells utilized in these experiments led us to 
hypothesize that the cellular density plays a role in the level of IgA transcytosis in vitro. To test 
this idea, we performed two-fold serial dilutions of the cells seeded in the Transwells (Figure 
2.15a). Both the undiluted (using ~5x10
5
 cells as above) and a 1:2 dilution showed similar 
amounts of transcytosed IgA. However, a 1:4 dilution reproducibly showed significantly less 
transcytosed IgA. Furthermore, apical media collected from a 1:8 dilution showed IgA at levels 
below the limit of detection. This result suggested that there was an intact monolayer at this cell 
density but no detectable IgA was transcytosed. At a 1:16 dilution, we could not reproducibly 
achieve a monolayer, as in some experiments, IgA was readily detected in the apical 
compartment at levels similar to the basolateral chamber.  TER measurements corroborated these 
findings.  Higher cell densities all showed resistance values of >2500 Ωcm2 (Figure 2.15b). The 
TER for the 1:8 cell dilution was more variable, with average values of ~1240 Ωcm2. The TER 
for the 1:16 dilution was near baseline values. 
 The cell density was quantified for each dilution by nuclei counts of whole mount images 
of bis-benzimide-stained Transwell membranes (Figure 2.16). A 1:2 dilution of input cells 
resulted in only a small change in the number of seeded cells on the Transwell, indicating that 
maximum cell numbers were seeded at these two input densities. Each successive two-fold 
dilution showed a ~two-fold decrease in cell density. We next tested whether the correlation of 
cell density to IgA transcytosis was due to cell number and/or pIgR expression. Co-staining of 
cells with anti-pIgR antisera showed detectable staining in the majority of cells in Transwells 
with higher cell densities (no dilution, 1:2 and 1:4). We observed a substantial decrease in the 
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number of cells that were positive for pIgR in 1:8 dilution samples. There was no detectable 
staining for pIgR in the 1:16 dilution samples. To confirm this observation, we performed gene 
expression analysis for pIgR at each dilution (Figure 2.17). The highest relative expression of 
pIgR was observed at the 1:2 and 1:4 dilution samples. We observed a threshold effect whereby 
pIgR expression was substantially lower in the 1:8 and 1:16 dilution samples. Our interpretation 
is that the decrease in IgA transcytosis that occurred between the 1:2 and the 1:4 dilutions is 
likely due to changes in cell density while the decrease in IgA trancytosis in the 1:8 dilution is 
likely further driven by diminished pIgR expression. One other possibility is that global 
differentiation is altered by decreased density. We found that markers of secretory lineages 
(Muc2 and Atoh1) were diminished in a density-dependent manner while a general marker of 
epithelial cells (Vil1) was not altered (Figure 2.18).   
 
Cytokines induce pIgR expression and IgA transcytosis in the primary Transwell cultures 
Several different cytokines were previously shown to induce pIgR expression in tumor 
cell lines including IL-1β, TNFα, IFN, and most recently, IL-1719,36,38,95-98. We wanted to test if 
primary intestinal epithelial cells responded similarly to these cytokines, and if so, what was the 
relative potency. To do this, we performed a dose titration using these four cytokines with IgA 
transcytosis and pIgR expression as readouts (Figure 2.19-2.21). IL-17 was the most potent 
cytokine tested. A dose of 0.5 ng/ml resulted in higher levels of IgA transcytosis than LPS 
treatment (Figure 2.19a). IL-1β and TNFα were both significantly less potent than IL-17, as a 
100 ng/ml dose of these cytokines only induced half the levels of IgA transcytosis as LPS 
(Figure 2.20a, 2.21a). Apical media from pIgR
-/- 
cells at all doses of IL-1β, TNFα, and IL-17 
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contained no IgA (Figure 2.19-2.21). For all three of these cytokines the dose response curves 
for pIgR expression mirrored the IgA transcytosis (Figure 2.19-2.21).  
 Of note, the results for IFN treatment were distinct from that of the other cytokines as 
well as previously published literature using immortalized cell lines (Figure 2.22). At 0.1-1 
ng/ml, the epithelial monolayer did not remain intact, as apical media from wild-type and pIgR
-/- 
cells both contained IgA levels similar to the media in the lower compartment (Figure 2.22a). 
Furthermore, TER measurements of cytokine-treated cells showed no measureable resistance 
after IFN treatment while treatment with IL-1β, TNFα, and IL-17 showed comparable TER 
values with LPS-treated cells (Figure 2.23). At lower doses (0.001-0.01 ng/ml), less IgA was 
present in the apical media, however none of these conditions led to an increase of pIgR mRNA 
expression (Figure 2.22b). Our conclusion is that IgA uses a paracellular route in IFN-treated 
cells that could either be due to cell death or leaky junctions.  
 
Colonic epithelial cells generated from Tlr4
-/-
 mice show reduced IgA transcytosis and pIgR 
expression after LPS but not IL-17 treatment 
One advantage of this system is the ability to isolate cells directly from different 
genetically modified mice for experiments. As a proof of principle, cells were harvested from 
Tlr4
-/-
 mice to generate colonic spheroids. These cells lack the LPS receptor, Tlr4, and therefore 
should have a reduced response to LPS stimulation. As expected, IgA transcytosis and pIgR 
expression was reduced to ~50% of that of wild-type cells (Figure 2.24). The ability of these 
cells to respond to other stimuli for IgA transcytosis was not affected, as IL-17 treatment of the 
Tlr4
-/-
 cells showed no difference from wild-type cells (Figure 2.25). 
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DISCUSSION         
We have established a new method to grow primary intestinal epithelial cells in a 
functional monolayer. To do this, we adapted the previously established 3D primary intestinal 
epithelial stem cell culture system
83,84
 to a 2D monolayer in a Transwell. The system we have 
developed has three important components. Firstly, the use of the L-WRN CM system allowed 
us to attain large cell numbers that are required to form monolayers in Transwells. Secondly, 
cells only needed to be grown in Matrigel culture for three days prior to recovery and seeding 
into Transwells. Lastly, seeded cells quickly formed polarized monolayers and demonstrated 
high TER values within three days. In contrast, previously established intestinal epithelial 
monolayer systems that utilize immortalized cell lines require as many as twenty days in culture 
to form differentiated, polarized monolayers
89-91
. 
 This system will be useful for the study of many different physiologic processes. Here, 
we chose to focus on IgA transcytosis. For this process to occur, epithelial cells must express the 
IgA receptor pIgR, which has been shown to be regulated by microbial products
31
.  LPS has been 
used as a standard in the field to induce pIgR expression in vitro. Typically immortalized cell 
lines have been used. Here we showed that LPS-treated primary intestinal epithelial cells were 
also able to induce pIgR expression. In addition, we found that maximal pIgR expression 
required DAPT treatment in addition to LPS, suggesting that the intestinal epithelial cells require 
differentiation for efficient pIgR expression. To demonstrate the robustness of primary intestinal 
epithelial cells for IgA transcytosis, we carefully analyzed several key factors including time, 
IgA dose, and LPS dose. We titrated the assay and chose to use 10 μM DAPT, 1 μg/ml LPS, and 
5 µg/ml IgA as our optimal conditions. The time course of a typical experiment is 10 hours with 
multiple samples taken from each Transwell.  
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 Interestingly, we found that cell density also affected IgA transcytosis. After recovery 
from the Matrigel, two-fold serial dilutions were made before seeding the cells in the Transwells. 
As it might be expected, we observed a cell density-dependent decrease in the amount of IgA 
transcytosed. However, this decrease in IgA was not just due to the decrease in cell number. 
Gene expression analysis of pIgR showed a substantial decrease at the lowest cell densities. 
Immunofluorescence staining for pIgR correlated with the mRNA expression data, showing 
fewer pIgR-positive cells at the lowest cell densities. We hypothesized the lower density cells 
may be in a less differentiated state, which has been shown in other in vitro cell systems
112-114
. 
We therefore tested the expression of other cell differentiation markers, including goblet cell 
marker Muc2 and a secretory cell lineage marker Atoh1, and found both to show a correlation of 
expression with cell density. This suggests that cell-to-cell endogenous signaling, and not solely 
exogenous chemical stimuli, regulate colonic cell differentiation in this culture system. 
 While LPS robustly induces pIgR expression, it is difficult to translate in vitro quantities 
to the biomass of intestinal microbes that generate this molecule. To make this system more 
applicable to specific bacteria, we utilized heat-killed bacteria. We therefore treated the cells 
with heat-killed E. coli and found that a dose of 10
7
 CFU/ml stimulated IgA transcytosis and 
pIgR expression to a similar extent as 1μg/ml LPS. We feel that this system will be useful for 
future studies looking at host-microbial interactions in vitro. 
 Previous studies found that several host cytokines including IL-1β, TNFα, IFN, and IL-
17 play a role in pIgR expression
36,38,95-98
. Similar to what has been shown in immortalized cell 
lines, IL-1β, TNFα, and IL-17 showed a dose-dependent induction of pIgR expression, with IL-
17 being the most potent inducer of IgA transcytosis and pIgR expression of these cytokines. 
However, an important difference we found between our primary mouse intestinal epithelial cells 
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and human cancer cell lines is the ability of IFN to induce pIgR expression. IFN treatment did 
not lead to pIgR expression or IgA transcytosis at any dose tested, and actually resulted in cell 
death at higher doses. This may be a result that would otherwise be obscured by using 
immortalized cell lines, which can be resistant to cytokine-induced cell death. Furthermore, this 
does not appear to be species-specific phenomenon, as the mouse promoter for pIgR is highly 
conserved to the human promoter and also contains the IRF1 binding site
115
.  
 One final important advantage of this system is the ability to readily use primary 
intestinal epithelial cells taken from different genetically modified mice. In this study, we 
utilized cells obtained from available lines of knockout mice for the pIgR and Tlr4 genes. 
Monolayers of epithelial cells derived from these mice allowed us to directly address questions 
using cells with complete loss-of-function, as compared to the usual incomplete loss of function 
with shRNA knockdowns.  
 
Prospectus- In summary, we developed a new system to culture primary intestinal epithelial cells 
in monolayer culture. While we have highlighted the capability of this system to be utilized for 
studies of IgA transcytosis, there are many other experimental avenues where this system should 
prove to be useful. These areas include barrier function, host-microbial interactions and 
epithelial-immune/stromal cell interactions. We propose that not only will this system be useful 
for mechanistic studies, but also for large-scale chemical biology screens in these arenas.   
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Figure 2.1. Timeline for primary intestinal epithelial monolayer formation.  
Schematic of timeline for Transwell experiments. Primary intestinal epithelial stem cells 
originally isolated from the colons of wild type mice were passaged and maintained in 3D 
spheroid cultures in Matrigel. To seed into Transwells (day zero), three-day old spheroids were 
recovered from Matrigel, trypsinized, and dissociated by vigorous pipetting. Cells were passed 
through a 40 μm cell strainer and re-suspended in 50% L-WRN CM containing 10 μM Y-27632. 
On day one post-seeding, cells were treated with +/- 10 μM DAPT +/- 1 μg/ml LPS and utilized 
on day three post-seeding for various assays. 
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Figure 2.1. Timeline for primary intestinal epithelial monolayer formation. 
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Figure 2.2. Primary IECs form a polarized monolayer that can be induced to express pIgR. 
Wild type cells were treated with +/- 10 μM DAPT +/- 1 μg/ml LPS and analyzed on day three 
post-seeding. Cells were fixed and paraffin-embedded on the transwell membranes. Sections 
were cut and stained with the following: (a) hematoxylin and eosin, (b) anti-ZO-1, (c) anti-villin, 
(d) anti-CD138, and (e) anti-pIgR. Bars = 50 μm. Representative images are shown. 
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Figure 2.2. Primary IECs form a polarized monolayer that can be induced to express pIgR. 
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Figure 2.3. Primary IEC monolayers can differentiate into various cell types. 
Wild type cells were treated with 10 μM DAPT and 1 μg/ml LPS and analyzed on day three 
post-seeding. Cells were fixed on the transwell membranes and stained for (a)  Chromogranin A 
and (b) UEA-1 lectin (arrowheads). Representative whole mount images are shown. 
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Figure 2.3. Primary IEC monolayers can differentiate into various cell types. 
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Figure 2.4. Primary IEC monolayers mirror in vivo staining patterns of the colonic surface 
epithelium. 
Colons from wild type mice were harvested, bouins-fixed, and paraffin embedded. 5 μm 
histologic sections were cut and stained for (a) CD138, (b) chromogranin A, (c) UEA-1, (d) 
villin1, and (e) ZO-1. Bars = 200 μm. Yellow boxes denote area depicted in insets. 
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Figure 2.4. Primary IEC monolayers mirror in vivo staining patterns of the colonic surface 
epithelium. 
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Figure 2.5. Colonic epithelial cells express pIgR in vivo. 
Colons from (a) wild type mice or (b) pIgR
-/-
 mice were harvested, bouins-fixed, and paraffin 
embedded. 5 μm histologic sections were cut and stained for pIgR. Bars = 200 μm. Yellow boxes 
denote area depicted in insets. 
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Figure 2.5. Colonic epithelial cells express pIgR in vivo. 
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Figure 2.6. Primary IEC monolayers express pIgR mRNA in vitro. 
Wild type cells were treated with +/- 10 μM DAPT +/- 1 μg/ml LPS and analyzed on day three 
post-seeding. Gene expression analysis was performed by qRT-PCR for pIgR. All samples were 
normalized to Gapdh mRNA, and data were presented as fold change relative to untreated (0% 
CM) cells (mean ± s.e.m.; n ≥ 3 per condition). One-way ANOVA: F = 96.02, P < 0.0001. 
Means with different letters are significantly different by Bonferroni’s multiple comparison test 
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Figure 2.6. Primary IEC monolayers express pIgR mRNA in vitro. 
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Figure 2.7. Primary IEC monolayers express Reg3g and Vil1 mRNA in vitro. 
Wild type cells were treated with +/- 10 μM DAPT +/- 1 μg/ml LPS and analyzed on day three 
post-seeding. Gene expression analysis was performed by qRT-PCR for (a) Reg3g, and (b) Vil1. 
All samples were normalized to Gapdh mRNA, and data were presented as fold change relative 
to untreated (0% CM) cells (mean ± s.e.m.; n ≥ 3 per condition). One-way ANOVA: (a) F = 
3.441, P < 0.0376; (b) F = 1.085, P < 0.3762. 
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Figure 2.7. Primary IEC monolayers express Reg3g and Vil1 mRNA in vitro. 
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Figure 2.8. Primary IEC monolayers show robust transepithelial electrical resistance. 
Wild type cells were treated with +/- 10 μM DAPT +/- 1 μg/ml LPS. Transepithelial electrical 
resistance was measured on day three post seeding. The (resistance x area) is shown for each 
condition (mean ± s.e.m., n = 6 per group). Statistical analysis by Student’s t-test showed no 
significant difference between the two groups (P < 0.4362).  
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Figure 2.8. Primary IEC monolayers show robust transepithelial electrical resistance. 
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Figure 2.9. Schematic for IgA transcytosis assay. 
Wild type and pIgR
-/-
 cells were seeded in Transwells and treated with +/- 10 μM DAPT +/-1 
μg/ml LPS as indicated. On day three post-seeding, 40 μl of normal mouse IgA (Santa Cruz) was 
added to the lower compartment of the Transwells (a), and supernatants from the upper 
compartment were taken at six hours for the detection of IgA by ELISA (b). 
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Figure 2.9. Schematic for IgA transcytosis assay. 
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Figure 2.10. IgA transcytosis by primary IEC monolayers mirrors pIgR expression. 
Wild type and pIgR
-/-
 cells were seeded in Transwells and treated with +/- 10 μM DAPT +/-1 
μg/ml LPS as indicated. On day three post-seeding, 40 μl of normal mouse IgA (Santa Cruz) was 
added to the lower compartment of the Transwells, and supernatants from the upper 
compartment were taken at six hours for the detection of IgA by ELISA. The dotted lines 
represent the limit of detection by the ELISA. All values are indicated as mean ± s.e.m. One-way 
ANOVA: F = 573.3, P < 0.0001, n ≥ 3 per group. Means with different letters are significantly 
different by Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.10. IgA transcytosis by primary IEC monolayers mirrors pIgR expression. 
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Figure 2.11. IgA transcytosis time course by primary IEC monolayers. 
Wild type and pIgR
-/-
 cells were seeded in Transwells and treated with +/- 10 μM DAPT +/-1 
μg/ml LPS as indicated. On day three post-seeding, 40 μl of normal mouse IgA (Santa Cruz) was 
added to the lower compartment of the Transwells, and supernatants from the upper 
compartment were taken at various time points for the detection of IgA by ELISA. The dotted 
lines represent the limit of detection by the ELISA. All values are indicated as mean ± s.e.m. 
One-way ANOVA: F = 539.2, P < 0.0001, n ≥ 12 per group. Means with different letters are 
significantly different by Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.11. IgA transcytosis time course by primary IEC monolayers. 
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Figure 2.12. Determining the optimal IgA concentration for IgA transcytosis. 
Wild type and pIgR
-/-
 cells were seeded in Transwells and treated with +/- 10 μM DAPT +/-1 
μg/ml LPS as indicated. On day three post-seeding, various concentrations of normal mouse IgA 
was added to the lower compartment of the Transwells, and supernatants from the upper 
compartment were taken at three and/or six hours for the detection of IgA by ELISA. The dotted 
lines represent the limit of detection by the ELISA. (a) Normal mouse IgA from Santa Cruz 
Biotechnology was evaluated, and 40 µl/well was chosen for experiments. (b) Determining a 
comparable IgA dose from BD Pharmingen. 
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Figure 2.12. Determining the optimal IgA concentration for IgA transcytosis. 
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Figure 2.13. Determining the optimal LPS concentration for IgA transcytosis. 
An LPS dose curve was performed on WT and pIgR
-/-
 cells to determine whether IgA 
transcytosis (a) and pIgR expression (b) were dose dependent. All LPS-treated cells were also 
treated with 10 μM DAPT. For IgA transcytosis, results from the ELISA were normalized to the 
1 μg/ml LPS treatment group (= 100%). Gene expression analysis by qRT-PCR for pIgR was 
performed by normalizing to Gapdh, and data are presented as fold change relative to untreated 
cells. The dotted lines represent the limit of detection by the ELISA. All values are indicated as 
mean ± s.e.m. One-way ANOVA: (a) F = 675.7, P < 0.0001, n ≥ 3 per group; (b) F = 46.22, P < 
0.0001, n ≥ 6 per group.  Means with different letters are significantly different by Bonferroni’s 
multiple comparison test. N.D. = not detected. 
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Figure 2.13. Determining the optimal LPS concentration for IgA transcytosis. 
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Figure 2.14. Heat-Killed E.coli can induce IgA transcytosis and pIgR expression. 
Wild type and pIgR
-/-
 cells were seeded in Transwells and treated with 10 μM DAPT and 1 μg/ml 
LPS or 10
7
 CFU/ml heat-killed E.coli as indicated. (a) IgA transcytosis was analyzed by ELISA, 
and results were normalized to the WT+DAPT+LPS group (= 100%). (b) Gene expression 
analysis by qRT-PCR of pIgR was performed and all samples were normalized to Gapdh. Data 
are presented as fold change relative to untreated (0% CM) cells. All values are indicated as 
mean ± s.e.m. One-way ANOVA: (a) F = 426.2, P < 0.0001, n ≥ 6 per group, means with 
different letters are significantly different by Bonferroni’s multiple comparison test; (b) F = 
11.47, P < 0.0008, n ≥ 5 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.14. Heat-Killed E.coli can induce IgA transcytosis and pIgR expression. 
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Figure 2.15. Cell density affects IgA transcytosis and monolayer formation. 
Two-fold serial dilutions of wild type cells were seeded into Transwells and treated with 10 μM 
DAPT and 1 μg/ml LPS. (a) IgA transcytosis was performed on day three post-seeding, and 
measurement of IgA in the supernatants at the six hour time point is shown. The dotted lines 
represent the limit of detection by the ELISA. All values are indicated as mean ± s.e.m. One-way 
ANOVA: (a) F = 53.11, P < 0.0001, n ≥ 6 per group. Means with different letters are 
significantly different by Bonferroni’s multiple comparison test. (b) Transepithelial electrical 
resistance was measured on day three. The (resistance x area) is shown for each condition (mean 
± s.e.m., n > 4 per group). N.D. = not detected. 
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Figure 2.15. Cell density affects IgA transcytosis and monolayer formation. 
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Figure 2.16. Cell density affects pIgR protein expression. 
Two-fold serial dilutions of wild type cells were seeded into Transwells and treated with 10 μM 
DAPT and 1 μg/ml LPS. Cells were fixed and stained on the Transwell membranes (a) with anti-
pIgR (green) and bis-benzamide dye (blue). Bars = 200 μm. (b) Quantification of cell density of 
cells on Transwells was performed using ImageJ software. All values are indicated as mean ± 
s.e.m. One-way ANOVA: (b) F = 183.2, P < 0.0001, n ≥ 15 per group. Means with different 
letters are significantly different by Bonferroni’s multiple comparison test. 
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Figure 2.16. Cell density affects pIgR protein expression. 
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Figure 2.17. Cell density affects pIgR mRNA expression. 
Two-fold serial dilutions of wild type cells were seeded into Transwells and treated with 10 μM 
DAPT and 1 μg/ml LPS. Gene expression analysis was performed by qRT-PCR for pIgR. All 
samples were normalized to Gapdh, and data are presented as fold change relative to untreated 
(0% CM) cells. All values are indicated as mean ± s.e.m. One-way ANOVA: F =  39.02, P < 
0.0001, n ≥ 3 per group. Means with different letters are significantly different by Bonferroni’s 
multiple comparison test. 
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Figure 2.17. Cell density affects pIgR mRNA expression. 
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Figure 2.18. Cell density affects intestinal epithelial monolayer differentiation. 
Two-fold serial dilutions of wild type cells were seeded into Transwells and treated with 10 μM 
DAPT and 1 μg/ml LPS. Gene expression analysis was performed by qRT-PCR for (a) Muc2, 
(b) Atoh1, and (c) Vil1. All samples were normalized to Gapdh, and data are presented as fold 
change relative to untreated (0% CM) cells. All values are indicated as mean ± s.e.m. One-way 
ANOVA: (a) F = 11.07, P < 0.0001, n ≥ 3 per group; (b) F = 3.436, P < 0.0183, n ≥ 3 per group; 
(c) F = 2.186 , P < 0.0894, n ≥ 3 per group. Means with different letters are significantly 
different by Bonferroni’s multiple comparison test. 
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Figure 2.18. Cell density affects intestinal epithelial monolayer differentiation. 
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Figure 2.19. IL-17 robustly induces IgA transcytosis and pIgR expression. 
Wild type and pIgR
-/-
 cells were treated with 10 μM DAPT and varying doses of IL-17. (a)  IgA 
transcytosis was analyzed by ELISA, and results were normalized to the WT+DAPT+LPS group 
(= 100%). (b) Gene expression analysis of pIgR was performed and all samples were normalized 
to Gapdh. Data are presented as fold change relative to untreated (0% CM) cells. All values are 
indicated as mean ± s.e.m. One-way ANOVA: (a) F = 152.3, P < 0.0001, n ≥ 3 per group; (b) F 
= 119.5, P < 0.0001, n ≥ 4 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.19. IL-17 robustly induces IgA transcytosis and pIgR expression. 
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Figure 2.20. IL-1β can induce IgA transcytosis and pIgR expression. 
Wild type and pIgR
-/-
 cells were treated with 10 μM DAPT and varying doses of IL-1β. (a)  IgA 
transcytosis was analyzed by ELISA, and results were normalized to the WT+DAPT+LPS group 
(= 100%). (b) Gene expression analysis of pIgR was performed and all samples were normalized 
to Gapdh. Data are presented as fold change relative to untreated (0% CM) cells. All values are 
indicated as mean ± s.e.m. One-way ANOVA: (a) F = 187.9, P < 0.0001, n ≥ 3 per group; (b) F 
= 49.92, P <0.0001, n ≥ 5 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.20. IL-1β can induce IgA transcytosis and pIgR expression. 
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Figure 2.21. TNFα can induce IgA transcytosis and pIgR expression. 
Wild type and pIgR
-/-
 cells were treated with 10 μM DAPT and varying doses of TNFα. (a)  IgA 
transcytosis was analyzed by ELISA, and results were normalized to the WT+DAPT+LPS group 
(= 100%). (b) Gene expression analysis of pIgR was performed and all samples were normalized 
to Gapdh. Data are presented as fold change relative to untreated (0% CM) cells. All values are 
indicated as mean ± s.e.m. One-way ANOVA: (a) F = 376.7, P < 0.0001, n ≥ 3 per group; (b) F 
= 28.29, P < 0.0001, n ≥ 4 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.21. TNFα can induce IgA transcytosis and pIgR expression. 
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Figure 2.22. IFNγ does not induce pIgR expression. 
Wild type and pIgR
-/-
 cells were treated with 10 μM DAPT and varying doses of IFNγ. (a) IgA 
transcytosis was analyzed by ELISA, and results were normalized to the WT+DAPT+LPS group 
(= 100%). The no cell group indicates the amount of IgA that freely diffuses into the apical 
supernatant in the absence of cells in the Transwell. (b) Gene expression analysis of pIgR was 
performed and all samples were normalized to Gapdh. Data are presented as fold change relative 
to untreated (0% CM) cells. All values are indicated as mean ± s.e.m. One-way ANOVA: (b) F = 
35.17, P < 0.0001, n ≥ 5 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.22. IFNγ does not induce pIgR expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
Figure 2.23. IFNγ-treated cells do not maintain an intact monolayer. 
Transepithelial electrical resistance measurements were taken on day three after treatment with 
10 μM DAPT and the highest previously used dose of various cytokines (100 ng/ml IL-1β, 100 
ng/ml TNFα, 20 ng/ml IL-17, 1 ng/ml IFNγ). All values are indicated as mean ± s.e.m. One-way 
ANOVA: F = 19.23, P < 0.0001, n ≥ 4 per group. Means with different letters are significantly 
different by Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.23. IFNγ-treated cells do not maintain an intact monolayer. 
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Figure 2.24. Cells from Tlr4
-/-
 mice have an impaired IgA transcytosis response to LPS. 
Wild type Tlr4 and Tlr4
-/-
 were treated with 10 μM DAPT and 1 μg/ml LPS. (a) IgA transcytosis 
was measured by ELISA and results were normalized to the WT group (= 100%). Values are 
indicated as mean ± s.e.m.; n = 8 per group. Wilcoxon signed rank test: P = 0.0039. (b) Gene 
expression analysis of pIgR was performed and all samples were normalized to Gapdh. Data are 
presented as fold change relative to untreated (0% CM) cells. All values are indicated as mean ± 
s.e.m. One-way ANOVA: F = 40.92, P < 0.0001, n ≥ 7 per group. Means with different letters 
are significantly different by Bonferroni’s multiple comparison test. 
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Figure 2.24. Cells from Tlr4
-/-
 mice have an impaired IgA transcytosis response to LPS. 
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Figure 2.25. Tlr4
-/-
 cells induce IgA transcytosis and pIgR expression in response to IL-17. 
Wild type Tlr4 and Tlr4
-/-
 cells were treated with 10 μM DAPT and varying doses of IL-17. (a) 
IgA transcytosis was analyzed by ELISA and results were normalized to the WT+D+L group (= 
100%). Gene expression analysis of pIgR was performed (b) and all samples were normalized to 
Gapdh. Data are presented as fold change relative to untreated (0% CM) cells. All values are 
indicated as mean ± s.e.m. One-way ANOVA: (a) F = 116.9, P < 0.0001, n ≥ 3 per group; (b) F 
= 6.364, P < 0.0004, n ≥ 3 per group. Means with different letters are significantly different by 
Bonferroni’s multiple comparison test. N.D. = not detected. 
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Figure 2.25. Tlr4
-/-
 cells induce IgA transcytosis and pIgR expression in response to IL-17. 
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CHAPTER THREE 
 
Heritable Luminal IgA Levels Distinguish Extra-Chromosomal Phenotypic Variation 
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ABSTRACT 
IgA is the most abundant immunoglobulin produced in the body. The majority of the IgA can 
be found at mucosal sites such as the intestine where it plays an important role at a critical 
intersection between the host immune system and the microbiota. Mice of the same genetic 
background bred in the same facility were surprisingly found to have dichotomous fecal IgA 
levels. This phenotype was heritable and transmissible but was not due to a genetic effect. 
Furthermore, the IgA-Low phenotype was dominant and microbially driven. One functional 
consequence of the IgA-Low phenotype was increased damage in response to chemically-
induced intestinal injury, which was observed to be directly dependent on the IgA status. In 
addition, these results indicate that the IgA-Low mice have biologically active microbes with 
proteolytic capability, leading to the degradation of SC and IgA in vitro and in vivo. Therefore, 
these data show that the microbiota can modulate fecal IgA levels, leading to phenotypic 
variation in mice.  
 
 
 
 
 
 
 
 
 
 
 
87 
 
INTRODUCTION 
It is often assumed in mouse models that genotypic differences determine phenotypic 
differences as long as all experimental animals are bred in the same facility or are ordered from 
the same supplier. However, phenotypic variation of mice that are apparently genetically 
identical in different facilities is a well-recognized problem often leading to opposing 
conclusions
62,68,69
. There have been many examples showing that the bacterial microbiome 
(inherited from the dam in mice
57-59
) has major influences on intestinal phenotypes. Garrett et al 
have found that K. pneumonia and P. mirabilis correlates with the development of spontaneous 
disease in the TRUC (Tbet
-/-
 Rag
-/-
 ulcerative colitis) mouse model
63
. Through cross-fostering 
experiments, maternal transmission of bacteria was shown to be able to induce disease in the 
TRUC mice as well as the littermate controls that do not normally develop spontaneous disease 
(Rag2
-/-
 and WT). Similarly, Elinav et al have shown that mice deficient in inflammasome 
components (ASC
-/-
, NLRP6
-/-
, IL-18
-/-
) exhibit exacerbated intestinal injury to dextran sodium 
sulfate (DSS), which correlated with the presence of Prevotella species
64
. Cross-fostering 
experiments with these mice also revealed that the colitogenic activity of the microbiota was 
transferable to WT mice. Though one conclusion was that NLRP6 directly regulated the 
composition of the gut microbiota, since littermates were not used in the initial studies (or in the 
16S sequencing studies), it is possible that the differences in the microbiota resulted from 
differences in ancestry. Several more examples of this can be seen in the literature
65,67
. 
A nice study performed by Ubeda et al showed that in contrast to what had been 
previously thought, deficiency in Myd88, TLR2, TLR4, TLR5, and TLR9 had minimal impact 
on the microbial composition relative to WT littermates under homeostatic conditions
66
. 
Therefore, their conclusions were that the differences previously found between these TLR-
88 
 
deficient strains and their non-littermate WT controls reflected long-term divergence and drift of 
the microbiota that was maternally transmitted in these separate breeding schemes (despite being 
in the same mouse facility).   
Though it is clear that the microbiota can change intestinal phenotypes such as the 
susceptibility of mice to intestinal injury, specific host-microbial mechanisms responsible have 
not been defined. Here, we investigated the surprising observation that wild-type mice bred 
within the same facility had dichotomous fecal IgA levels (IgA-High or IgA-Low). This 
phenotype was heritable, but not due to mouse genetics. Instead bacteria in IgA-Low mice 
dominantly lowered IgA levels in IgA-High mice after either co-housing or fecal transplantation. 
This property of inherited bacteria was not unique to a single facility. The dominant effect of 
bacteria from IgA-Low mice was stably passaged through mice lacking luminal IgA indicating 
that the heritable property of the IgA phenotype was not selected by the IgA itself.  In response 
to DSS, IgA-Low mice showed increased colonic ulceration that was driven by fecal IgA 
differences. Serum IgA levels and intestinal plasma cell numbers were not altered, indicating that 
the B cell compartment did not drive the IgA-Low phenotype. Instead, bacteria from IgA-Low 
mice degraded the secretory component of SIgA. These studies highlight the ability of the 
microbiota to produce phenotypic effects through the modulation of IgA, and underscore the 
importance of taking into account the non-chromosomal hereditary variation between different 
breeders when making phenotypic comparisons between mice. 
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MATERIALS AND METHODS             
Mice. Animal protocols were approved by the Washington University Animal Studies 
Committee. All mice were maintained in one of two a specific pathogen-free barrier facilities, 
with different procedures for maintaining food, water, and caging. In the SRF facility, complete 
cages (including food, bedding, isolator top, wires, and cage) are autoclaved after assembly, 
water is autoclaved and kept sterile, and a higher concentration of disinfectant is used (1:5:1 
Clidox, Pharmacal Research Laboratories, Inc.). The CSRB facility also uses autoclaved cage 
components however the cages are assembled after autoclaving. The food is irradiated but not 
autoclaved, and a lower concentration of disinfectant is used (1:18:1 Clidox).  pIgR
-/-
 mice 
(B6.129P2-Pigr
tm1Fejo
/Mmmh
43
) were initially obtained from Mutant Mouse Regional Resource 
Center and were backcrossed to 98% B6. All mice used were 3-6 months of age.  
 
Mouse treatments. For fecal transplantation experiments, fecal samples were collected from 
mice and resuspended in sterile PBS to a final concentration of 200 mg/ml by weight. Mice were 
administered 25 μl of the fecal mixture on two consecutive days. 
 Antibiotics were administered in drinking water for 14 days. Treatments included 1 
mg/ml vancomycin, 1mg/ml neomycin, 1mg/ml ampicillin, and 1mg/ml metronidazole. 
For dextran sodium sulfate experiments, 2.5% DSS (TdB Consultancy) was administered 
in drinking water for 11 days. Mice were weighed daily and sacrificed at 70% of initial body 
weight if needed. Intestines were taken for histology.   
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Preparation of fecal samples for ELISA and immunoblotting. Fecal samples were collected 
from mice and resuspended in sterile PBS to a final concentration of 100 mg/ml by weight. 
Supernatants were collected and stored in -20°C until needed.  
 
Preparation of fecal samples for bacterial culture. Fecal samples were collected from mice 
and resuspended in sterile PBS to a final concentration of 200 mg/ml by weight. 250 μl of this 
mixture was used to inoculate anaerobic chopped meat broth in Hungate tubes (Fisher Scientific) 
for overnight cultures in a 37°C shaking incubator. The fecal suspensions as well as the 
overnight cultures were used in epithelial co-culture experiments described below. 
 
Primary intestinal epithelial cell culture. Primary colonic epithelial stem cells were isolated, 
grown, and maintained as 3D spheroid cultures in Matrigel (BD Biosciences) as described in 
Miyoshi et al
83,84
. Cells were kept in 50% L-WRN conditioned media (CM). Media was changed 
every two days, and cells were passaged every three days (1:3 split).  
Primary intestinal epithelial cell monolayers were formed as described in Moon et al
116
. 
Briefly, spheroids were recovered from three-day-old 3D Matrigel cultures, trypsinized, 
dissociated to single cells by vigorous pipetting, and re-suspended in 50% L-WRN CM 
containing 10 μM Y-27632 (R&D Systems). These cells were plated in Transwell inserts 
(Corning Costar) coated with 0.1% gelatin.  
 
Cell treatments. On day one (24 hours after seeding the Transwells) the 50% L-WRN CM 
supplemented with Y-27632 was removed and replaced with 0% CM (Advanced DMEM/F12 
containing 20% FBS, 100 units of Penicillin, 0.1 mg/ml Streptomycin and 2 mM L-glutamine). 
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At this time, any additional treatments were also administered to the cells: 1 μg/ml LPS (Sigma), 
and 10 μM DAPT -secretase inhibitor (Millipore).  Cells were given fresh media with the 
respective treatments on day two, and were treated for a total of 48 hours before being used for 
IgA transcytosis on day three.  
 
IgA transcytosis assay. On day three, the Transwells were removed from the various treatment 
conditions, and switched to base media (Advanced DMEM/F12 supplemented with 2mM L-
glutamine only; no FBS, no antibiotics).  600 μl of base media containing 3 μg of mouse IgA 
(BD Pharmingen) was added to the lower compartment (final concentration of IgA = 5 μg/ml). 
100 μl of base media (with or without various treatments) was added to the upper compartment. 
Treatments included 1:10 fecal bacterial suspensions and 1:10 overnight anaerobic chopped meat 
bacterial cultures. The apical supernatant was collected at different time points to evaluate the 
amount of pIgR and IgA transcytosed by immunoblotting and ELISA (Immunology Consultants 
Labs).   
 
Immunostaining and histologic analysis. For whole tissue immunostaining, mouse colons were 
harvested and prepared as previously described
102
. 5 μm thick transverse sections were cut for 
hematoxylin and eosin staining and immunostaining. For this procedure, the sections were de-
paraffinized, hydrated, boiled in Trilogy solution (Cell Marque) for 20 minutes, rinsed in PBS, 
blocked with 1% bovine serum albumin/0.1% Tritin-X100 for 30 minutes, and incubated with 
primary antibody at 4°C overnight. Primary antibodies include: goat anti-mouse pIgR (1:500, 
R&D Systems) and goat anti-mouse IgA-AlexaFluor 488 (1:200, Serotec). The slides were 
rinsed three times in PBS and incubated with AlexaFluor594-conjugaed species-specific 
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secondary antibodies for one hour at room temperature (1:500, Invitrogen) if needed. Slides were 
washed three times in PBS and stained with bis-benzimide/Hoechst (Invitrogen) to visualize 
nuclei and mounted with a 1:1 PBS:glycerol solution. Staining was visualized with a Zeiss 
Axiovert 200 microscope with an Axiocam MRM digital camera. 
 
Immunoblotting. Protein was isolated from intestinal tissue segments of ~1cm in 500 μl RIPA 
buffer with protease inhibitors using the Fastprep bead-beater system (MP Bio, BioSpec). 
Samples were subjected to 4 rounds of lysis at a speed 6 for 20 seconds, at 4°C. Primary 
intestinal epithelial cells were lysed in Transwells with 50 μl RIPA buffer with protease 
inhibitors (Sigma). Total protein was quantified using Pierce BCA Protein Assay Kit (Thermo 
Scientific). Supernatants from fecal samples and Transwells were taken as described above. 
Samples were run on either Any kD or 7.5% Mini-Protean TGX gels (Bio‐Rad) and transferred 
onto nitrocellulose membrane (Bio‐Rad). Membranes were blocked with 3% milk in 0.1% 
Tween‐20 Tris‐buffered saline for 1 h at room temperature and probed with goat IgG anti-pIgR 
(R&D) and rabbit IgG anti-Actin (Sigma) overnight at 4°C. Blots were incubated for 1 h with 
horseradish peroxidase‐conjugated secondary antibodies (Invitrogen, BioRad) before 
development using the SuperSignal West Dura chemiluminescent kit (Thermo Scientific). 
Immunoblots were quantified using ImageJ software
101
. 
 
Statistical Analysis. Statistical significance between groups was determined using unpaired t‐
test, One-way analysis of variance, Two-way analysis of variance, and repeated measures Two-
way analysis of variance in Prism GraphPad Software. 
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RESULTS 
Low fecal IgA levels in WT C57BL/6 mice is heritable, transferable, and dominant 
While interrogating baseline levels of fecal IgA in WT C57BL/6J mice (B6) bred in our 
mouse colony, we observed a binary phenotype in fecal IgA levels between cages (Fig 3.1): 
those with high fecal IgA (defined as greater than 0.05 µg IgA/mg feces), and those with nearly 
undetectable levels of fecal IgA (hereafter designated as IgA-High and IgA-Low mice). This 
differential IgA phenotype was observed in two separate facilities at our institution in WT B6 
colonies that were independently derived (Fig 3.2). While both facilities are specific pathogen-
free, the procedures, protocols, access, and personnel are unique. All experiments were 
performed in both facilities unless otherwise noted. Despite the profound difference in fecal IgA 
levels, serum IgA levels were similar between these two groups, suggesting an effect localized to 
the gut (Fig 3.3). The binary phenotype was vertically transmissible, indicating a heritable 
phenotype (Fig 3.4). Furthermore, this heritable phenotype was laterally transferable by co-
housing IgA-High and IgA-Low WT B6 mice. Remarkably, both IgA-High and IgA-Low mice 
were found to be IgA-Low post-co-housing (Fig 3.5). This result also occurred by cross-transfer 
experiments which involved fecal transplantation between mice in our two facilities (Fig 3.6). 
Hence, the IgA-Low phenotype was dominant, indicating that IgA levels can be regulated by 
suppression and not only induction.  
 
The IgA-Low phenotype is bacterially driven  
We next tested if the fecal microbiome in the absence of IgA could create this binary 
phenotype. To address this experimentally, we used pIgR
-/-
 mice that cannot transcytose IgA (and 
therefore lack luminal IgA)
43
 as vessels to passage microbes independently of IgA (Fig 3.7). 
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Fecal samples from pIgR
-/-
 mice transplanted with IgA-Low material were able to subsequently 
confer the IgA-Low phenotype to IgA-High WT recipient mice (Fig 3.8). As a control, WT IgA-
High recipients maintained their phenotype when transplanted with samples from IgA-High-
transplanted pIgR
-/-
 mice. Thus, exposure to a novel environment lacking IgA (the pIgR
-/-
 
intestine) does not affect the ability of the fecal microbiota to regulate the IgA-High vs -Low 
phenotype.  
Both commensal bacteria and viruses in the gut modulate mucosal IgA levels
117,118
. To 
assess whether dominant lowering of IgA levels was due to bacteria or alternatively viral or 
soluble factors, we transplanted IgA-High mice with fecal material from IgA-Low mice that had 
been either homogenized or filtered to remove large microbes (e.g. bacteria, fungi). IgA-High 
mice transplanted with filtered fecal material remained IgA-High, while mice transplanted with 
unfiltered fecal homogenate became IgA-Low (Fig 3.9). This result suggests the IgA-Low 
phenotype is induced by intestinal microbes, and excludes filterable viruses.  
 To determine if specific microbial pools could induce the IgA-Low phenotype, we pre-
treated IgA-Low mice with a broad-spectrum antibiotic cocktail (vancomycin, neomycin, 
ampicillin, and metronidazole; VNAM) chosen to target a wide range of microbes
119,120
 (Fig 
3.10a,b), then transplanted them fecal samples from either IgA-High or IgA-Low mice. 
Transplantation with IgA-High microbes led to an increase of intestinal IgA levels, indicating 
that the IgA-Low-inducing microbes were eliminated by VNAM (Fig 3.10b). We then tested the 
role of specific antibiotics and found that ampicillin but not metronidazole was sufficient to 
reverse the IgA-Low phenotype (Fig 3.10c,d). These results show ampicillin-sensitive 
microbe(s) were responsible for the IgA-Low phenotype. Unlike VNAM, ampicillin treatment 
reversed the IgA-low phenotype even without transplantation with IgA-High samples. This 
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indicated that VNAM eliminated both the IgA suppressive and IgA-inductive microbes while 
ampicillin alone eliminated only the IgA-suppressive microbes. We assessed whether the IgA 
status of antibiotic-treated mice could be vertically transmitted, and found that VNAM-treated 
IgA-Low mice transplanted with IgA-High fecal samples gave rise to IgA-High progeny (Fig 
3.11). Taken together, these results support a model where the IgA-low phenotype is bacterially-
driven, dominantly transmissible, and heritable (Figure 3.12).  
 
Functional consequences of low fecal IgA levels: increased susceptibility to colonic injury 
We next determined if the IgA-Low phenotype affected intestinal injury responses as 
previous studies that showed pIgR
-/-
 mice are more susceptible to DSS injury
121
. With DSS 
treatment, IgA-Low mice lost significantly more weight than their IgA-High counterparts (Fig 
3.13), and exhibited increased distal colon ulceration (Fig 3.14). This DSS sensitivity could be 
secondary to either diminished IgA or the altered microbial composition. 
To address this we re-colonized WT and pIgR
-/-
 mice with IgA-High or IgA-Low fecal 
material for two weeks after VNAM treatment, as shown in Figure 3.7, prior to DSS treatment 
(Fig 3.15). As expected, WT IgA-Low mice showed enhanced DSS sensitivity compared to WT 
IgA High mice (Fig 3.16, 3.17). Consistent with previous reports
121
, we observed that pIgR
-/-
 
mice exhibited increased weight loss and colonic ulceration compared to WT mice. Interestingly, 
this sensitivity was independent of the microbial composition. This finding implied that altered 
IgA levels, and not the microbes themselves, were responsible for the increased DSS damage in 
WT IgA-Low mice.  
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Identifying the mechanism: IgA-Low-associated microbes degrade SIgA 
To study the mechanism by which IgA-Low microbes suppress fecal IgA levels, we 
assessed IgA production and IgA transport capacity by pIgR in IgA-High vs IgA-Low mice. 
Intestinal IgA is made in the lamina propria by plasma cells, but we found no difference in 
plasma cell numbers in small intestines or colons of these mice (Fig 3.18). Immunofluorescence 
staining for pIgR in the IgA-High and IgA-Low mice also failed to show obvious differences 
(Fig 3.19).  
On the apical surface of intestinal epithelial cells, pIgR is cleaved and released into the 
intestine bound to dimeric IgA. This cleaved form of pIgR, called the secretory component (SC), 
is thought to help protect dimeric IgA from degradation by bacterial proteases
13,14
. We 
hypothesized that in IgA-Low mice, the absence of IgA may be secondary to degradation of SC. 
We therefore assessed levels of cleaved (SC) vs. full-length (membrane-bound) pIgR by 
immunoblots fecal samples and whole tissue (Fig 3.20a). While both IgA-High and -Low mice 
had comparable levels of pIgR in whole tissue (Fig 3.20b,c), IgA-Low mice had significantly 
reduced levels of SC in fecal samples (Fig 3.20d).  
 To define the mechanism for this observation, we developed an in vitro system. We first 
anaerobically cultured bacteria from IgA-High and IgA-Low fecal samples (Fig 3.21a), and 
administered these cultures to IgA-High recipients. While the IgA-High cultures maintained the 
IgA-High phenotype, mice administered IgA-Low cultures converted to the IgA-Low phenotype, 
indicating the causative IgA-Low microbes are culturable in these conditions (Fig 3.21b).  We 
next generated polarized, differentiated monolayers of primary epithelial cells in Transwells
116
 
and assessed IgA transport from the basolateral to the apical compartment in the presence of the 
cultured bacteria (Fig. 3.22). Treatment with the γ-secretase inhibitor DAPT and LPS robustly 
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induces pIgR in these cells (Fig. 3.23), which is necessary for IgA transport (Fig 3.24). We then 
co-cultured epithelial monolayers with IgA-High or IgA-Low cultures by adding pelleted 
bacteria or culture supernatants to the apical compartment of the Transwells for three or six 
hours (Fig 3.24). In co-cultures with IgA-High pelleted bacteria, we detect SC in the apical 
supernatants at both time points, while co-cultures with IgA-Low pelleted bacteria exhibited 
substantially greater SC degradation over time. The bacterial culture supernatants did not lead to 
degradation, suggesting that the presence of the bacterial cells is required in this case. Epithelial 
cell lysates from all treatment conditions showed similar pIgR levels, indicating that differences 
in SC levels in the supernatant are not due to differences in epithelial pIgR expression (Fig. 
3.23).  
 Taken together, these data suggest there are bacteria present in the IgA-Low microbiota 
capable of degrading SC in vitro, consistent with our observation of absent fecal SC in vivo. 
These findings are consistent with a model in which SC degradation by IgA-Low microbes 
makes IgA more susceptible to degradation itself (Fig 3.25). Bacteria have been shown to make 
proteases that can cleave human IgA1/IgA2 as well as SC
70-73,76-78
, though this has not been 
addressed in murine models, and could be a potential means by which the causative IgA-Low 
microbes alter the host response. 
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DISCUSSION 
Here, we show one driver of phenotypic variation between genetically identical mice 
bred in the same colonies. We found that fecal IgA levels show a binary phenotype in WT mice 
that was heritable and transferable. In addition, the IgA-Low phenotype was found to be 
dominant and microbially driven. One functional consequence of having low levels of luminal 
IgA was increased intestinal injury after DSS treatment in mice. Furthermore, in vitro co-culture 
experiments using primary epithelial monolayers and anaerobically cultured intestinal bacteria 
showed that cultured microbes from IgA-Low mice had proteolytic activity capable of degrading 
SC. Previous studies from multiple groups have shown that SC stabilizes and protects dIgA from 
degradation by proteases
13,14
, thus these findings support the idea that degradation of SC in vivo 
would make IgA more susceptible to degradation itself, and thereby explain the IgA-Low 
phenotype.   
This data reveals that the microbiome can potentially mimic the effects of chromosomal 
genes, such that phenotypes of mouse strains bred separately may reflect significant biological 
effects of the microbiome
122
. Therefore, in order to evaluate the effects of a chromosomal gene 
(especially in the intestine), the effects of the microbiome must be taken into consideration as 
well. In these studies, fecal IgA served as a readily measurable marker for relevant effects of the 
bacterial microbiome, and it is possible that its use might clarify variation that can occur within 
some mouse experiments. Furthermore, fecal transplantation and co-housing experiments could 
also serve as a methodological control for the phenotypic variation dependent on heritable 
factors that may be easily transmissible between hosts. Our findings may have broader 
implications for many animal experiments since the microbiome has also been shown to have 
systemic effects
123
. 
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Figure 3.1. Wild type C57BL/6 mice have a binary fecal IgA phenotype. 
Fecal IgA normalized by weight was measured by anti-mouse IgA enzyme linked 
immunosorbent assay (ELISA). The IgA-High phenotype was defined as having fecal IgA values 
>0.05 μg IgA/mg feces. The dotted lines represent the limit of detection by ELISA. All values 
are indicated as mean±s.e.m. Statistical analysis by unpaired t-test: P<0.0001, n>34 mice per 
group. 
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Figure 3.1. Wild type C57BL/6 mice have a binary fecal IgA phenotype. 
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Figure 3.2. The binary fecal IgA phenotype is observed in two independent facilities. 
Fecal IgA (normalized to fecal weight) from mice housed in either Facility 1 or Facility 2 was 
detected by anti-mouse IgA ELISA. The dotted lines represent the limit of detection by ELISA. 
All values are indicated as mean±s.e.m. One-way analysis of variance: F=44.59, P<0.0001, n>12 
mice per group. Means with different letters are significantly different by Tukey’s multiple 
comparison test. 
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Figure 3.2. The binary fecal IgA phenotype is observed in two independent facilities. 
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Figure 3.3. Serum IgA is comparable between IgA-High and IgA-Low mice. 
Serum IgA was measured by anti-mouse IgA ELISA. All values are indicated as mean±s.e.m. 
Statistical analysis by unpaired t-test: P<0.3991, n=12 mice per group. 
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Figure 3.3. Serum IgA is comparable between IgA-High and IgA-Low mice. 
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Figure 3.4. The binary fecal IgA phenotype is heritable. 
Fecal IgA was analyzed from IgA-High/IgA-Low breeders and their progeny once they reached 
at least 8 weeks of age. The dotted lines represent the limit of detection by ELISA. All values are 
indicated as mean±s.e.m. One-way analysis of variance: F= 45.95, P<0.0001, n>9 mice per 
group. Means with different letters are significantly different by Tukey’s multiple comparison 
test. 
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Figure 3.4. The binary fecal IgA phenotype is heritable. 
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Figure 3.5. The IgA-Low phenotype is dominantly transferable by co-housing. 
Fecal IgA was measured in IgA-High and IgA-Low mice before and after 14 days of 1:1 co-
housing. The dotted lines represent the limit of detection by ELISA. All values are indicated as 
mean±s.e.m. One-way analysis of variance: F= 15.56, P<0.0001, n>8 mice per group. Means 
with different letters are significantly different by Tukey’s multiple comparison test. 
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Figure 3.5. The IgA-Low phenotype is dominantly transferable by co-housing. 
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Figure 3.6. The IgA-Low phenotype is transferable between two independent mouse 
facilities.  
WT IgA-High mice from one mouse facility were administered homogenized fecal material from 
WT IgA-High or IgA-Low mice from the other mouse facility, and fecal IgA was measured 14 
days later by anti-mouse IgA ELISA. The dotted lines represent the limit of detection by ELISA. 
(a) Facility 1 mice pre- and post-fecal transplantation with Facility 2 fecal samples. (b) Facility 2 
mice pre- and post-fecal transplantation with Facility 1 fecal samples. All values are indicated as 
mean±s.e.m. One-way analysis of variance: (a) F=20.93, P<0.0001, n>8 mice per group; (b) 
F=12.92, P<0.0004, n>4 mice per group. Means with different letters are significantly different 
by Tukey’s multiple comparison test.   
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Figure 3.6. The IgA-Low phenotype is transferable between two independent mouse facilities. 
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Figure 3.7. Schematic for passage experiment though pIgR
-/-
 mice. 
Schematic for re-population of antibiotic-treated pIgR
-/-
 mice with microbes from WT IgA-High 
or IgA-Low mice by fecal transplantation (FT), followed by fecal transplantation of WT IgA-
High recipients with samples from the re-populated pIgR
-/-
 mice. VNAM = antibiotic cocktail 
containing vancomycin, neomycin, ampicillin, metronidazole. 
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Figure 3.7. Schematic for passage experiment though pIgR
-/-
 mice. 
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Figure 3.8. The binary IgA phenotype can be passaged though pIgR
-/-
 mice. 
Fecal IgA levels from mice on day 44 as depicted in Figure 3.7. The dotted lines represent the 
limit of detection by ELISA. All values are indicated as mean±s.e.m. Statistical analysis by 
unpaired t-test: P<0.0003, n=8 mice per group. 
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Figure 3.8. The binary IgA phenotype can be passaged though pIgR
-/-
 mice. 
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Figure 3.9. The IgA-Low phenotype can be transferred by fecal transplantation. 
Fecal IgA levels from IgA-High mice pre- and post-fecal transplantation with unfiltered (Post-
FT) or 0.45µm-filtered fecal material (Post-filter FT) from IgA-Low mice. The dotted lines 
represent the limit of detection by ELISA. All values are indicated as mean±s.e.m. One-way 
analysis of variance: F=5.685, P<0.0076, n>5 mice per group. Means with different letters are 
significantly different by Tukey’s multiple comparison test. 
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Figure 3.9. The IgA-Low phenotype can be transferred by fecal transplantation.  
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Figure 3.10. The IgA-Low phenotype is driven by ampicillin-susceptible bacteria. 
(a) Schematic of antibiotic treatment + fecal transplantation experiments performed in (b-d). 
Mice were treated with (b) a cocktail of antibiotics including vancomycin, neomycin, ampicillin, 
and metronidazole (VNAM), (c) ampicillin, or (d) metronidazole for 14 days prior to fecal 
transplantation with IgA-High or IgA-Low fecal samples. Fecal IgA levels were measured 14 
days after transplantation. The dotted lines represent the limit of detection by ELISA. All values 
are indicated as mean±s.e.m. One-way analysis of variance: (b) F=16.15, P<0.0001, n>9 mice 
per group; (c) F=22.96, P<0.0001, n>12 mice per group; (d) F=6.525, P<0.0012, n>5 mice per 
group. Means with different letters are significantly different by Tukey’s multiple comparison 
test. 
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Figure 3.10. The IgA-Low phenotype is driven by ampicillin-susceptible bacteria. 
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Figure 3.11. The converted IgA-High phenotype is stable and heritable. 
IgA-Low mice converted to IgA-High from (e) were used to set up a breeding pair, and fecal IgA 
levels of their progeny were measured once they reached at least 8 weeks of age. The dotted lines 
represent the limit of detection by ELISA. All values are indicated as mean±s.e.m. One-way 
analysis of variance: F=18.29, P<0.0002, n=2 breeders and n=10 progeny from 4 litters. Means 
with different letters are significantly different by Tukey’s multiple comparison test. 
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Figure 3.11. The converted IgA-High phenotype is stable and heritable. 
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Figure 3.12. Summary model of the IgA phenotype. 
Cartoon summarizing the IgA phenotype observed in WT mice in our mouse colonies. (a) The 
binary IgA phenotype is vertically transmitted and therefore heritable. (b) The IgA-Low 
phenotype is horizontally transmitted by co-housing in a dominant manner. (c) The IgA-Low 
phenotype is horizontally transmitted by fecal transplantation. Additional experiments suggest 
that the IgA-Low phenotype is driven by ampicillin-susceptible bacteria.  
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Figure 3.12. Summary model of the IgA phenotype. 
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Figure 3.13. The IgA-Low mice have greater weight loss in DSS injury. 
IgA-High and IgA-Low mice from both facilities were treated with 2.5% DSS in drinking water 
for 11 days. Mice were weighed daily and weight loss depicted as percent initial weight. All 
values are indicated as mean±s.e.m. Statistical analysis by Two-way repeated measures analysis 
of variance: column factor P<0.0089, n>8 mice per group. ***P<0.001 by Sidak’s multiple 
comparison test for the final time point. 
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Figure 3.13. The IgA-Low mice have greater weight loss in DSS injury. 
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Figure 3.14. The IgA-Low mice have increased ulceration in DSS injury. 
IgA-High and IgA-Low mice from both facilities were treated with 2.5% DSS in drinking water 
for 11 days, when colons were harvested for histology. (a) Representative hematoxylin and eosin 
stained histologic sections. Bars = 1 mm; boxes indicate areas of ulceration. (b)  percentage of 
ulcerated distal colon. All values are indicated as mean±s.e.m. Statistical analysis by unpaired t-
test: P<0.0385, n>10 mice per group.  
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Figure 3.14. The IgA-Low mice have increased ulceration in DSS injury. 
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Figure 3.15. IgA status of mice after VNAM and FT, before the start of DSS treatment. 
Fecal IgA levels were measured in mice from Figures 3.16 and 3.17 after VNAM treatment and 
IgA-High/IgA-Low fecal transplantation, prior to the start of DSS treatment. The dotted lines 
represent the limit of detection by ELISA. All values are indicated as mean±s.e.m. Statistical 
analysis by unpaired t-test: P<0.0001, n=7 mice per group.  
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Figure 3.15. IgA status of mice after VNAM and FT, before the start of DSS treatment. 
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Figure 3.16. The increased DSS-induced weight loss of IgA-Low mice is due to altered IgA 
levels. 
DSS treatment of WT and pIgR
-/- 
mice from Facility 2 after 14 days of VNAM treatment and 
IgA-High/IgA-Low fecal transplantation. Mice were treated with 2.5% DSS in drinking water for 
11 days, and weighed daily. Weight loss is depicted as percent initial weight. All values are 
indicated as mean±s.e.m. Statistical analysis by Two-way repeated measures analysis of 
variance: column factor P<0.0001, n>15 mice per group. Means with different letters are 
significantly different by Tukey’s multiple comparison test for the final time point. 
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Figure 3.16. The increased DSS-induced weight loss of IgA-Low mice is due to altered IgA 
levels. 
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Figure 3.17. The increased DSS-induced ulceration of IgA-Low mice is due to altered IgA 
levels. 
DSS treatment of WT and pIgR
-/- 
mice from Facility 2 after 14 days of VNAM treatment and 
IgA-High/IgA-Low fecal transplantation. Mice were treated with 2.5% DSS in drinking water for 
11 days, when colons were harvested for histology. (a) Representative hematoxylin and eosin 
stained histologic sections. Bars = 1 mm; boxes indicate areas of ulceration. (b)  percentage of 
ulcerated distal colon. All values are indicated as mean±s.e.m. Statistical analysis by One-way 
analysis of variance: F=8.272, P<0.0007, n>3 mice per group. Means with different letters are 
significantly different by Tukey’s multiple comparison test.  
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Figure 3.17. The increased DSS-induced ulceration of IgA-Low mice is due to altered IgA 
levels. 
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Figure 3.18. Intestinal plasma cell numbers are unchanged between IgA-High and IgA-Low 
mice.  
Ileal (a,b) and colonic (c,d) sections from IgA-High and IgA-Low mice were stained with anti-
IgA (green) and bis-benzamide dye (blue); representative images are shown. Bars = 100 μm. 
Quantification of ileal plasma cells per villus (e) and colonic plasma cells per 20X field (f) based 
on IgA staining. All values are indicated as mean±s.e.m. Statistical analysis by unpaired t-test: 
(e) P<0.6638, n=10 mice per group, and (f) P<0.3158, n>9 mice per group. 
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Figure 3.18. Intestinal plasma cell numbers are unchanged between IgA-High and IgA-Low 
mice. 
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Figure 3.19. Intestinal pIgR immunostaining is not different between IgA-High and IgA-
Low mice. 
Ileal (a,b) and colonic (c,d) sections from IgA-High and IgA-Low mice were stained with anti-
pIgR (red) and bis-benzamide dye (blue); representative images are shown (n=10 mice per 
group). Bars = 100 μm. 
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Figure 3.19. Intestinal pIgR immunostaining is not different between IgA-High and IgA-Low 
mice. 
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Figure 3.20. Secretory component is absent in IgA-Low fecal samples. 
(a) Representative anti-pIgR/SC immunoblot of intestinal tissue and fecal samples from IgA-
High (lanes 1-4) and IgA-Low (lanes 5-7) mice. Ileal and colonic pIgR was normalized to actin. 
Fecal samples were normalized by fecal weight. (b-d) Quantification of immunoblots for (b) 
ileal pIgR, (c) colonic pIgR, and (d) fecal SC using ImageJ. Colonic and ileal pIgR were 
normalized to actin, and fecal SC was normalized to average IgA-High values=100%. All values 
are indicated as mean±s.e.m. Statistical analysis by unpaired t-test: (b) P<0.6150, n>5 mice per 
group; (c) P<0.0933, n>10 mice per group; (d) P<0.0001, n>5 mice per group.  
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Figure 3.20. Secretory component is absent in IgA-Low fecal samples. 
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Figure 3.21. The IgA-Low-associated microbes are culturable. 
(a) Schematic of bacterial culturing experiments. (b) Fecal IgA was measured in IgA-High mice 
before and after administration with cultured microbes as depicted in (a). The dotted lines 
represent the limit of detection by ELISA. All values are indicated as mean±s.e.m. One-way 
analysis of variance: F=18.60, P<0.0001, n>9 mice per group. Means with different letters are 
significantly different by Tukey’s multiple comparison test. 
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Figure 3.21. The IgA-Low-associated microbes are culturable. 
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Figure 3.22: Schematic of intestinal epithelial:bacterial co-culture for IgA transcytosis 
On day 3 post seeding primary intestinal epithelial cell monolayers, 3 μg of normal mouse IgA is 
added to the lower compartment of the Transwells. At the same time, IgA-High or IgA-Low 
bacterial cultures are added to the apical compartment of the Transwells. Apical Transwell 
supernatants are collected at 3 and 6 hours for detection of SIgA by various methods. 
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Figure 3.22: Schematic of intestinal epithelial:bacterial co-culture for IgA transcytosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
143 
 
Figure 3.23. pIgR is expressed equally in intestinal epithelial monolayers in all treatment 
conditions.  
Representative immunoblot of intestinal epithelial monolayers stained for anti-pIgR and anti-
actin (one of three experiments). Cells were pre-treated with 10 μM DAPT + 1μg ml-1 LPS on 
days 1 and 2 post seeding to induce differentiation and pIgR expression. Some wells were left 
untreated as negative controls. On day 3 post seeding, 3 μg of normal mouse IgA was added to 
the lower compartment of the Transwells. At the same time, a subset of the DAPT+LPS-treated 
Transwells was also treated with IgA-High/IgA-Low bacterial cultures (either the pelleted 
bacterial or supernatant fraction) in the apical compartment. 
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Figure 3.23. pIgR is expressed equally in intestinal epithelial monolayers in all treatment 
conditions. 
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Figure 3.24. IgA-Low cultured microbes degrade SC in vitro. 
Primary intestinal epithelial cell monolayers were pre-treated with 10 μM DAPT + 1μg ml-1 LPS 
on days 1 and 2 post seeding to induce differentiation and pIgR expression. Some wells were left 
untreated as negative controls. On day 3 post seeding, 3 μg of normal mouse IgA was added to 
the lower compartment of the Transwells. At the same time, a subset of the DAPT+LPS-treated 
Transwells was also treated with IgA-High/IgA-Low bacterial cultures (either the pelleted 
bacterial or supernatant fraction) in the apical compartment. Apical Transwell supernatants were 
collected at 3 and 6 hours, and the amount of SC was measured by anti-SC immunoblot. (a) 
Representative anti-SC immunoblot and quantification of the full length SC normalized to the 
DAPT+LPS treatment group at 3 hours (b) and 6 hours (c) over 5 independent experiments by 
ImageJ. All values are indicated as mean±s.e.m. One-way analysis of variance: (b) F=13.50, 
P<0.0001, n>3 per group; (c) F=62.56, P<0.0001, n=5 per group. Means with different letters are 
significantly different by Tukey’s multiple comparison test. 
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Figure 3.24. IgA-Low cultured microbes degrade SC in vitro. 
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Figure 3.25. Summary and working model. 
Wild-type mice bred in the same facility have a binary phenotype in fecal IgA levels (IgA-High 
vs IgA-Low). This phenotype was found to be heritable and transmissible. Surprisingly, the IgA-
Low phenotype was dominant and microbially driven by ampicillin-susceptible bacteria. These 
IgA-Low mice had an increased susceptibility to DSS injury that was directly dependent on the 
IgA status. Mechanistically, we found the IgA-Low microbes had proteolytic activity in vitro, 
leading to the degradation of SC. This is consistent with the model in which SC degradation by 
IgA-Low microbes would make IgA more susceptible to degradation itself. 
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Figure 3.25. Summary and working model. 
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CHAPTER FOUR 
 
Summary and future directions 
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SUMMARY 
The overarching theme of this thesis was to investigate host-microbial interactions in the 
intestine. More specifically, we were interested in investigating the role of IgA, which is at a 
critical intersection between the host immune system and the microbiota. To do this, we 
developed an in vitro system and utilized in vivo mouse models to examine a mechanism by 
which commensal bacteria can modulate luminal IgA. 
The first aim was to develop a primary intestinal epithelial monolayer system to study the 
cell biology of intestinal epithelial cells in vitro. Until recent advancements allowing for the 
culture and propagation of primary intestinal epithelial stem cells in vitro
82-84
, various colon 
cancer cells lines and non-intestinal epithelial cell lines have been utilized to model physiologic 
and cell biologic processes. While studies using Caco-2, HT-29, T84, MDCK, and other cell 
lines have provided invaluable insights into epithelial cell biology, there are many well-
recognized limitations to these systems
85,86,89-91
. However, one of the major advantages these 
various cell lines have over the current primary cell culture systems is their ability to form 
polarized monolayers. We therefore adapted the primary spheroid culture system to grow 
polarized primary intestinal epithelial cell monolayers, and functionally tested these monolayers 
by looking at the process of IgA transcytosis
116
. Our ultimate goal was to be able to use this 
system to not only investigate epithelial cell biology, but also epithelial cell interactions with 
other host cells as well as the commensal microbiota. 
Our in vivo studies highlight the ability of the microbiota to produce significant 
phenotypic effects in genetically identical mice. We found that WT mice in a single mouse 
facility had dichotomous levels of fecal IgA, and this phenotype was found to be heritable in a 
non-chromosomal manner. In addition, the IgA-Low phenotype was found to be dominant, 
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microbially driven, and led to increased intestinal injury by DSS. In vitro co-culture studies 
utilizing the primary intestinal epithelial monolayer system and anaerobically cultured bacteria 
revealed proteolytic activity present in the IgA-Low cultured microbes that led to the degradation 
of SC. These findings are consistent with a model in which SC degradation by IgA-Low 
microbes makes IgA more susceptible to degradation itself, leading to the low IgA levels 
observed in these mice. The studies presented in this thesis have just begun to dive into the 
mechanism of this microbially driven phenotypic difference, and brings up multiple avenues for 
future studies that are the subject of this final chapter. 
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FUTURE DIRECTIONS 
As detailed in chapter 3 and summarized in Figure 3.25, we observed that genetically 
identical mice in the same facility had a dichotomous fecal IgA phenotype that was heritable and 
transmissible. Furthermore, the IgA-Low phenotype was found to be dominant and microbially 
driven. In vitro studies utilizing the primary intestinal epithelial monolayers along with 
anaerobically cultured bacteria from the mice indicated that the IgA-Low-associated microbes 
may have proteolytic activity capable of degrading SC (Fig. 3.24). This is consistent with the 
model in which SC degradation by these IgA-Low microbes would make IgA more susceptible 
to degradation itself, potentially explaining the diminished luminal IgA levels in the IgA-Low 
mice.  
Preliminary experiments using the epithelial:bacterial cell co-culture system show that in 
fact IgA itself may be degraded in vitro (Figure 4.1). Treatment of the epithelial monolayers 
with the IgA-Low culture supernatants showed comparable levels of IgA in the apical Transwell 
compartment to the DAPT+LPS treated positive controls. However, co-culture of the monolayers 
with the bacterial fraction from the IgA-Low culture showed IgA levels near the lower limit of 
detection. This data suggested that the IgA-Low microbes have a biologic effect on the IgA itself 
in addition to the SC in vitro. Further experiments need to be performed using cultured microbes 
from IgA-High mice as a control. In addition, to show that this decrease in SC and IgA is due to 
biologic effects of the microbes, these studies need to be repeated using heat-killed and 
antibiotic-treated bacterial cultures. To show that the decrease in SIgA is specifically due to 
proteolytic degradation, broad-spectrum bacterial protease inhibitors can be used during the co-
culture experiments. Not all bacterial proteases may be inhibited by these cocktails, however if 
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inhibition was observed, specific bacterial protease inhibitors can be used to classify and narrow 
down the type of protease(s) involved in the IgA-Low phenotype. 
Also at this point, we cannot determine whether the microbes affecting SC levels are the 
same ones affecting IgA levels. To do this, we would first need to identify specific bacterial 
isolates that are capable of degrading SC and IgA in vitro. While we have been successful in 
culturing a community of microbes from IgA-Low mice that is able to confer the IgA-Low 
phenotype in vivo and degrade SC and IgA in vitro, we have had some difficulty growing 
specific bacterial isolates. Through 16S sequencing (Figure 4.2), we have identified Prevotella 
and Sutterella as potential candidates associated with the IgA-Low phenotype. These microbes 
were present in the IgA-Low mice, but absent in the IgA-High mice. We will attempt to isolate 
single colonies of Prevotella and Sutterella on LKV and Brucella blood agar respectively. It is 
possible that while these microbes show an association by sequencing, they may not be the 
protease-producing microbes directly responsible for the degradation of the SIgA. These 
microbes may be acting in concert with other bacteria to produce this effect or may need a 
community of microbes to grow efficiently in culture.  
Therefore a complementary approach will be used to identify the microbe(s) with IgA-
degrading activity utilizing a functional screen. To do this, different combinations of antibiotics 
will be added to the IgA-Low chopped meat broth cultures to selectively eliminate pools of 
bacteria while trying to retain the IgA-Low inducing microbes. In addition, dose curves of the 
antibiotics could be tested. The in vitro co-culture system will allow us to systematically and 
efficiently test these pools of microbes without initially worrying about potential issues of 
intestinal colonization in the in vivo model.  
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Furthermore, the in vitro assay could be further simplified to a no-cell system: cultured 
microbes could be added to media containing SIgA to look for direct degradation as an initial 
screen prior to using the co-culture system, allowing for an even quicker screening tool. Both 
mouse IgA and recombinant mouse SC are sold commercially and can be incubated in vitro to 
form SIgA complexes. While some optimization will need to be performed to set up this system, 
it would ultimately save time in performing the screen.  
In these approaches, we can functionally test pools of microbes using our in vitro co-
culture system and potentially narrow down our IgA-Low community without the pressure of 
relying on one single isolate that may or may not grow well in isolation. There is also the 
possibility that one bacterial species alone may not be able to induce the phenotype, and a 
community of microbes is needed. Using these approaches to gradually narrow down pools of 
bacteria would address that possibility. 
 In addition to identifying the IgA-Low phenotype-inducing bacteria, another big question 
is the identity of the putative protease. Knowing the identity of the bacteria would provide a 
great advantage in addressing this question. If we can identify a specific bacterial species, the 
genome sequence could provide insight into potential candidate proteases. Candidate genes could 
then be cloned into E.coli to test for SIgA-degrading activity. In addition, we could also try to 
isolate and purify the protease from the bacterial cultures. If the protease of interest can be 
identified, it would be interesting to determine the specificity of the protease: is SIgA a specific 
substrate, or is there a wider range of substrates that include additional host proteins, as observed 
for ZapA produced by P. mirabilis
79
? It would be interesting to determine whether our 
microbe(s) of interest is(are) an opportunistic pathogen and/or a commensal microbe in the 
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mouse intestine, and whether these proteases function as virulence factors (which has typically 
been the case for the IgA proteases found thus far). 
 Looking at the bigger picture, it would be interesting to determine whether related 
microbes and/or proteases were present in the human intestine, and how this relates to luminal 
IgA levels in humans. While the majority of IgA is produced at mucosal sites such as the 
intestine, human IgA levels are mainly tested by serum analysis. Even in the case of IgA 
deficiency, the clinical diagnosis is performed by measuring serum IgA levels. And while 
alterations in IgA levels have been associated with intestinal diseases such as celiac disease and 
IBD, luminal IgA levels have not really been investigated in human patients. Our work has 
shown that serum IgA, lamina propria IgA
+
 plasma cell numbers, and epithelial pIgR expression 
may not necessarily correlate with IgA levels in the intestinal lumen (where IgA is thought to 
exert most of its effects). Therefore, the investigation of mucosal, and specifically luminal IgA 
levels in human patients would be of great value.  
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Figure 4.1. IgA-Low cultured microbes degrade SIgA in vitro 
Primary intestinal epithelial cell monolayers were pre-treated with 10 μM DAPT + 1μg ml-1 LPS 
on days 1 and 2 post seeding to induce differentiation and pIgR expression. Some wells were left 
untreated as negative controls. On day 3 post seeding, 3 μg of normal mouse IgA was added to 
the lower compartment of the Transwells. At the same time, a subset of the DAPT+LPS-treated 
Transwells was also treated with IgA-High/IgA-Low bacterial cultures (either the pelleted 
bacterial or supernatant fraction) in the apical compartment. Apical Transwell supernatants were 
collected at 3 and 6 hours, and the amount of IgA transcytosed to the apical compartment was 
measured by ELISA. The dotted lines represent the limit of detection by ELISA. All values are 
indicated as mean±s.e.m. One-way analysis of variance: F=43.15, P<0.0001, n>3 per group. 
Means with different letters are significantly different by Tukey’s multiple comparison test.  
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Figure 4.1. IgA-Low cultured microbes degrade SIgA in vitro 
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Figure 4.2. Identification of IgA-Low-associated microbes by 16S sequencing 
DNA was purified from IgA-High and IgA-Low fecal samples from two different mouse 
facilities (Facility 1 = CSRB, Facility 2 = SRF). Each sample was amplified in triplicate, 
combined, and confirmed by gel electrophoresis using Golay-barcoded primers specific for the 
V4 region (F515/R806). The final pooled samples were sent to the Center for Genome Sciences 
(Washington University School of Medicine) for sequencing using the 2x250bp protocol with the 
Illumina MiSeq platform. 16S sequence analysis was performed using QIIME (Quantitative 
Insights Into Microbial Ecology, version 1.8.0) (Caporaso et al., 2010). Relative OTU abundance 
data was input into LEfSe to determine biomarkers with significant LDA effect size (Segata et. al 
2010). Biomarkers were graphically annotated on phylogenetic trees using GraPhlAn (Segata et. 
al 2012). Depicted below are the biomarkers specific for the IgA-Low associated microbes. This 
work was performed by Dr. Megan T. Baldridge, M.D. Ph.D. 
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Figure 4.2. Identification of IgA-Low-associated microbes by 16S sequencing 
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